Username

Password

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Dietger Niederwieser

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Procedures

Disorders

Concepts & Ideas

Phenomena

Recurrence

Living Beings

Tissue Donors

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Gratwohl Alois; Stern Martin; Brand Ronald; Apperley Jane; Baldomero Helen; de Witte Theo; Dini Giorgio; Rocha Vanderson; Passweg Jakob; Sureda Anna; Tichelli André; Niederwieser Dietger;
Risk score for outcome after allogeneic hematopoietic stem cell transplantation: a retrospective analysis.
Ringdén Olle; Labopin Myriam; Ehninger Gerhard; Niederwieser Dietger; Olsson Richard; Basara Nadezda; Finke Juergen; Schwerdtfeger Rainer; Eder Matthias; Bunjes Donald; Gorin Norbert-Claude; Mohty Mohamad; Rocha Vanderson
Reduced intensity conditioning compared with myeloablative conditioning using unrelated donor transplants in patients with acute myeloid leukemia.
Ernst Thomas; Gruber Franz X; Pelz-Ackermann Oliver; Maier Jacqueline; Pfirrmann Markus; Müller Martin C; Mikkola Ingvild; Porkka Kimmo; Niederwieser Dietger; Hochhaus Andreas; Lange Thoralf
A co-operative evaluation of different methods of detecting BCR-ABL kinase domain mutations in patients with chronic myeloid leukemia on second-line dasatinib or nilotinib therapy after failure of imatinib.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Dietger Niederwieser (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Gratwohl Alois; Stern Martin; Brand Ronald; Apperley Jane; Baldomero Helen; de Witte Theo; Dini Giorgio; Rocha Vanderson; Passweg Jakob; Sureda Anna; Tichelli André; Niederwieser Dietger;
Risk score for outcome after allogeneic hematopoietic stem cell transplantation: a retrospective analysis.
Cancer 2009;115(20):4715-26.
2009: Ringdén Olle; Labopin Myriam; Ehninger Gerhard; Niederwieser Dietger; Olsson Richard; Basara Nadezda; Finke Juergen; Schwerdtfeger Rainer; Eder Matthias; Bunjes Donald; Gorin Norbert-Claude; Mohty Mohamad; Rocha Vanderson
Reduced intensity conditioning compared with myeloablative conditioning using unrelated donor transplants in patients with acute myeloid leukemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(27):4570-7.
2009: Ernst Thomas; Gruber Franz X; Pelz-Ackermann Oliver; Maier Jacqueline; Pfirrmann Markus; Müller Martin C; Mikkola Ingvild; Porkka Kimmo; Niederwieser Dietger; Hochhaus Andreas; Lange Thoralf
A co-operative evaluation of different methods of detecting BCR-ABL kinase domain mutations in patients with chronic myeloid leukemia on second-line dasatinib or nilotinib therapy after failure of imatinib.
Haematologica 2009;94(9):1227-35.
2009: de Witte Theo; Brand Ronald; van Biezen Anja; Mufti Ghulam; Ruutu Tapani; Finke Jürgen; von dem Borne Peter; Vitek Antonin; Delforge Michel; Alessandrino Paolo; Harlahakis Nicolas; Russell Nigel; Martino Roberto; Verdonck Leo; Kröger Nicholas; Niederwieser Dietger;
Allogeneic stem cell transplantation for patients with refractory anaemia with matched related and unrelated donors: delay of the transplant is associated with inferior survival.
British journal of haematology 2009;146(6):627-36.
2009: Ernst J; Schwarz R; Schwarzer A; Aldaoud A; Niederwieser D; Mantovani-Löffler L; Schröder C
[The role of next of kin in medical decision-making--empirical findings from haemato-oncological diseases]
Gesundheitswesen (Bundesverband der Ärzte des Öffentlichen Gesundheitsdienstes (Germany)) 2009;71(8-9):469-75.
2009: Al-Ali Haifa; Cross Michael; Lange Thoralf; Freund Matthias; Dölken Gottfried; Niederwieser Dietger
Low-dose total body irradiation-based regimens as a preparative regimen for allogeneic haematopoietic cell transplantation in acute myelogenous leukaemia.
Current opinion in oncology 2009;21 Suppl 1():S17-22.
2009: Krauter Jürgen; Wagner Katharina; Schäfer Irina; Marschalek Rolf; Meyer Claus; Heil Gerhard; Schaich Markus; Ehninger Gerhard; Niederwieser Dietger; Krahl Rainer; Büchner Thomas; Sauerland Cristina; Schlegelberger Brigitte; Döhner Konstanze; Döhner Hartmut; Schlenk Richard F; Ganser Arnold
Prognostic factors in adult patients up to 60 years old with acute myeloid leukemia and translocations of chromosome band 11q23: individual patient data-based meta-analysis of the German Acute Myeloid Leukemia Intergroup.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(18):3000-6.
2009: Fliedner Theodor M; Chao Nelson J; Bader Judith L; Boettger Axel; Case Cullen; Chute John; Confer Dennis L; Ganser Arnold; Gorin Norbert-Claude; Gourmelon Patrick; Graessle Dieter H; Krawisz Robert; Meineke Viktor; Niederwieser Dietger; Port Matthias; Powles Ray; Sirohi Bhawna; Weinstock David M; Wiley Albert; Coleman C Norman
Stem cells, multiorgan failure in radiation emergency medical preparedness: a U.S./European Consultation Workshop.
Stem cells (Dayton, Ohio) 2009;27(5):1205-11.
2009: Cordonnier Catherine; Labopin Myriam; Chesnel Virginie; Ribaud Patricia; De La Camara Rafael; Martino Rodrigo; Ullmann Andrew J; Parkkali Terttu; Locasciulli Anna; Yakouben Karima; Pauksens Karlis; Einsele Hermann; Niederwieser Dietger; Apperley Jane; Ljungman Per;
Randomized study of early versus late immunization with pneumococcal conjugate vaccine after allogeneic stem cell transplantation.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2009;48(10):1392-401.
2009: Rehak M; Müller M; Scholz M; Wiercinska J; Niederwieser D; Wiedemann P
[Antiphospholipid syndrome and retinal vein occlusion. Meta-analysis of Published Studies]
Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft 2009;106(5):427-34.
2009: Kröger Nicolaus; Brand Ronald; van Biezen Anja; Zander Axel; Dierlamm Judith; Niederwieser Dietger; Devergie Agnès; Ruutu Tapani; Cornish Jackie; Ljungman Per; Gratwohl Alois; Cordonnier Catherine; Beelen Dietrich; Deconinck Eric; Symeonidis Argiris; de Witte Theo;
Risk factors for therapy-related myelodysplastic syndrome and acute myeloid leukemia treated with allogeneic stem cell transplantation.
Haematologica 2009;94(4):542-9.
2009: Basara N; Schulze A; Wedding U; Mohren M; Gerhardt A; Junghanss C; Peter N; Dölken G; Becker C; Heyn S; Kliem C; Lange T; Krahl R; Pönisch W; Fricke H-J; Sayer H G; Al-Ali H; Kamprad F; Niederwieser D;
Early related or unrelated haematopoietic cell transplantation results in higher overall survival and leukaemia-free survival compared with conventional chemotherapy in high-risk acute myeloid leukaemia patients in first complete remission.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2009;23(4):635-40.
2009: Aglietta Massimo; Barkholt Lisbeth; Schianca Fabrizio Carnevale; Caravelli Daniela; Omazic Brigitta; Minotto Coludia; Leone Francesco; Hentschke Patrik; Bertoldero Giovanni; Capaldi Antonio; Ciccone Giovannino; Niederwieser Dietger; Ringdén Olle; Demirer Tanner;
Reduced-intensity allogeneic hematopoietic stem cell transplantation in metastatic colorectal cancer as a novel adoptive cell therapy approach. The European group for blood and marrow transplantation experience.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2009;15(3):326-35.
2009: Gratwohl A; Baldomero H; Schwendener A; Rocha V; Apperley J; Frauendorfer K; Niederwieser D;
The EBMT activity survey 2007 with focus on allogeneic HSCT for AML and novel cellular therapies.
Bone marrow transplantation 2009;43(4):275-91.
2009: Alt Rüdiger; Wilhelm Franziska; Pelz-Ackermann Oliver; Egger Dietmar; Niederwieser Dietger; Cross Michael
ABCG2 expression is correlated neither to side population nor to hematopoietic progenitor function in human umbilical cord blood.
Experimental hematology 2009;37(2):294-301.
2009: Bartsch Kristina; Al-Ali Haifa; Reinhardt Annette; Franke Christina; Hudecek Michael; Kamprad Manja; Tschiedel Sabine; Cross Michael; Niederwieser Dietger; Gentilini Chiara
Mesenchymal stem cells remain host-derived independent of the source of the stem-cell graft and conditioning regimen used.
Transplantation 2009;87(2):217-21.
2009: Halter Joerg; Kodera Yoshihisa; Ispizua Alvaro Urbano; Greinix Hildegard T; Schmitz Norbert; Favre Geneviève; Baldomero Helen; Niederwieser Dietger; Apperley Jane F; Gratwohl Alois
Severe events in donors after allogeneic hematopoietic stem cell donation.
Haematologica 2009;94(1):94-101.
2009: Aljurf M D; Zaidi S Z; El Solh H; Hussain F; Ghavamzadeh A; Mahmoud H K; Shamsi T; Othman T Ben; Sarhan M M; Dennison D; Ibrahim A; Benchekroun S; Chaudhri N; Labar B; Horowitz M; Niederwieser D; Gratwohl A
Special issues related to hematopoietic SCT in the Eastern Mediterranean region and the first regional activity report.
Bone marrow transplantation 2009;43(1):1-12.
2009: McCann S; Schwenkglenks M; Bacon P; Einsele H; D'Addio A; Maertens J; Niederwieser D; Rabitsch W; Roosaar A; Ruutu T; Schouten H; Stone R; Vorkurka S; Quinn B; Blijlevens N;
The Prospective Oral Mucositis Audit: relationship of severe oral mucositis with clinical and medical resource use outcomes in patients receiving high-dose melphalan or BEAM-conditioning chemotherapy and autologous SCT.
Bone marrow transplantation 2009;43(2):141-7.
2008: Kiefer Thomas; Krüger William H; Montemurro Michael; Schüler Frank; Hirt Carsten; Pasold Rita; Niederwieser Dietger; Schwenke Matthias; Dölken Gottfried
Mobilization of hemopoietic stem cells with high-dose methotrexate plus granulocyte-colony-stimulating factor in patients with primary central nervous system lymphoma.
Transfusion 2008;48(12):2624-8.
2008: Stelljes M; van Biezen A; Slavin S; Olavarria E; Clark R E; Nagler A; Koza V; Kienast J; Niederwieser D; de Witte T; Ruutu T;
The harvest and use of autologous back-up grafts for graft failure or severe GVHD after allogeneic hematopoietic stem cell transplantation: a survey of the European Group for Blood and Marrow Transplantation.
Bone marrow transplantation 2008;42(11):739-42.
2008: Pelz-Ackermann O; Cross M; Pfeifer H; Deininger M; Wang S-Y; Al-Ali H K; Niederwieser D; Lange T
Highly sensitive and quantitative detection of BCR-ABL kinase domain mutations by ligation PCR.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2008;22(12):2288-91.
2008: Kircher B; Niederwieser D; Gächter A; Lindner B; Mitterschiffthaler A; Urban C; Greinix H; Peters C; Lätzer K; Gastl G; Nachbaur D
T-cell precursor frequencies and long-term outcome following unrelated hematopoietic stem cell transplantation.
International journal of laboratory hematology 2008;30(6):499-507.
2008: Burroughs Lauri M; O'Donnell Paul V; Sandmaier Brenda M; Storer Barry E; Luznik Leo; Symons Heather J; Jones Richard J; Ambinder Richard F; Maris Michael B; Blume Karl G; Niederwieser Dietger W; Bruno Benedetto; Maziarz Richard T; Pulsipher Michael A; Petersen Finn B; Storb Rainer; Fuchs Ephraim J; Maloney David G
Comparison of outcomes of HLA-matched related, unrelated, or HLA-haploidentical related hematopoietic cell transplantation following nonmyeloablative conditioning for relapsed or refractory Hodgkin lymphoma.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2008;14(11):1279-87.
2008: Stern M; Brand R; de Witte T; Sureda A; Rocha V; Passweg J; Baldomero H; Niederwieser D; Gratwohl A
Female-versus-male alloreactivity as a model for minor histocompatibility antigens in hematopoietic stem cell transplantation.
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2008;8(10):2149-57.
2008: Sorror Mohamed L; Storer Barry E; Sandmaier Brenda M; Maris Michael; Shizuru Judith; Maziarz Richard; Agura Edward; Chauncey Thomas R; Pulsipher Michael A; McSweeney Peter A; Wade James C; Bruno Benedetto; Langston Amelia; Radich Jerald; Niederwieser Dietger; Blume Karl G; Storb Rainer; Maloney David G
Five-year follow-up of patients with advanced chronic lymphocytic leukemia treated with allogeneic hematopoietic cell transplantation after nonmyeloablative conditioning.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(30):4912-20.
2008: Pönisch Wolfram; Rozanski Marta; Goldschmidt Hartmut; Hoffmann Franz Albert; Boldt Thomas; Schwarzer Andreas; Ritter Ute; Rohrberg Robert; Schwalbe Elke; Uhlig Jens; Zehrfeld Thomas; Schirmer Veronika; Haas Antje; Kreibich Ute; Niederwieser Dietger;
Combined bendamustine, prednisolone and thalidomide for refractory or relapsed multiple myeloma after autologous stem-cell transplantation or conventional chemotherapy: results of a Phase I clinical trial.
British journal of haematology 2008;143(2):191-200.
2008: Gratwohl A; Baldomero H; Frauendorfer K; Niederwieser D;
Why are there regional differences in stem cell transplantation activity? An EBMT analysis.
Bone marrow transplantation 2008;42 Suppl 1():S7-S10.
2008: Tschiedel S; Gentilini C; Lange T; Wölfel C; Wölfel T; Lennerz V; Stevanovic S; Rammensee H-G; Huber C; Cross M; Niederwieser D
Identification of NM23-H2 as a tumour-associated antigen in chronic myeloid leukaemia.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2008;22(8):1542-50.
2008: Hudecek M; Bartsch K; Tschiedel S; Niederwieser D
[Minor antigens - major impact. The role of minor histocompatibility antigens in allogeneic hematopoietic stem cell transplantation]
Deutsche medizinische Wochenschrift (1946) 2008;133(28-29):1511-6.
2008: Fliedner Theodor M; Powles Ray; Sirohi Bhawna; Niederwieser Dietger;
Radiologic and nuclear events: the METREPOL severity of effect grading system.
Blood 2008;111(12):5757-8; author reply 5758-9.
2008: Messerer Dorle; Engel Jutta; Hasford Joerg; Schaich Markus; Ehninger Gerhard; Sauerland Cristina; Büchner Thomas; Schumacher Andrea; Krahl Rainer; Niederwieser Dietger; Krauter Jürgen; Ganser Arnold; Creutzig Ursula; Döhner Hartmut; Schlenk Richard F;
Impact of different post-remission strategies on quality of life in patients with acute myeloid leukemia.
Haematologica 2008;93(6):826-33.
2008: Hochhaus A; Baccarani M; Deininger M; Apperley J F; Lipton J H; Goldberg S L; Corm S; Shah N P; Cervantes F; Silver R T; Niederwieser D; Stone R M; Dombret H; Larson R A; Roy L; Hughes T; Müller M C; Ezzeddine R; Countouriotis A M; Kantarjian H M
Dasatinib induces durable cytogenetic responses in patients with chronic myelogenous leukemia in chronic phase with resistance or intolerance to imatinib.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2008;22(6):1200-6.
2008: Hirt Carsten; Schüler Frank; Kiefer Thomas; Schwenke Cornelia; Haas Antje; Niederwieser Dietger; Neser Sabine; Assmann Michael; Srock Stefanie; Rohrberg Robert; Dachselt Klaus; Leithäuser Malte; Rabkin Charles S; Herold Michael; Dölken Gottfried
Rapid and sustained clearance of circulating lymphoma cells after chemotherapy plus rituximab: clinical significance of quantitative t(14;18) PCR monitoring in advanced stage follicular lymphoma patients.
British journal of haematology 2008;141(5):631-40.
2008: Demirer Taner; Barkholt Lisbeth; Blaise Didier; Pedrazzoli Paolo; Aglietta Massimo; Carella Angelo Michele; Bay Jacques-Olivier; Arpaci Fikret; Rosti Giovanni; Gurman Gunhan; Niederwieser Dietger; Bregni Marco;
Transplantation of allogeneic hematopoietic stem cells: an emerging treatment modality for solid tumors.
Nature clinical practice. Oncology 2008;5(5):256-67.
2008: Gratwohl A; Baldomero H; Frauendorfer K; Rocha V; Apperley J; Niederwieser D;
The EBMT activity survey 2006 on hematopoietic stem cell transplantation: focus on the use of cord blood products.
Bone marrow transplantation 2008;41(8):687-705.
2008: Blijlevens Nicole; Schwenkglenks Matthias; Bacon Pamela; D'Addio Alessandra; Einsele Hermann; Maertens Johan; Niederwieser Dietger; Rabitsch Werner; Roosaar Ann; Ruutu Tapani; Schouten Harry; Stone Rebecca; Vokurka Samuel; Quinn Barry; McCann Shaun;
Prospective oral mucositis audit: oral mucositis in patients receiving high-dose melphalan or BEAM conditioning chemotherapy--European Blood and Marrow Transplantation Mucositis Advisory Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(9):1519-25.
2008: Ueno N T; Rizzo J D; Demirer T; Cheng Y C; Hegenbart U; Zhang M-J; Bregni M; Carella A; Blaise D; Bashey A; Bitran J D; Bolwell B J; Elfenbein G J; Fields K K; Freytes C O; Gale R P; Lazarus H M; Champlin R E; Stiff P J; Niederwieser D
Allogeneic hematopoietic cell transplantation for metastatic breast cancer.
Bone marrow transplantation 2008;41(6):537-45.
2008: Mellstedt H; Niederwieser D; Ludwig H
The challenge of biosimilars.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2008;19(3):411-9.
2008: Hochhaus Andreas; Druker Brian; Sawyers Charles; Guilhot Francois; Schiffer Charles A; Cortes Jorge; Niederwieser Dietger W; Gambacorti-Passerini Carlo; Stone Richard M; Goldman John; Fischer Thomas; O'Brien Stephen G; Reiffers Jose J; Mone Manisha; Krahnke Tillmann; Talpaz Moshe; Kantarjian Hagop M
Favorable long-term follow-up results over 6 years for response, survival, and safety with imatinib mesylate therapy in chronic-phase chronic myeloid leukemia after failure of interferon-alpha treatment.
Blood 2008;111(3):1039-43.
2008: Sureda Anna; Robinson Stephen; Canals Carmen; Carella Angelo M; Boogaerts Marc A; Caballero Dolores; Hunter Ann E; Kanz Lothar; Slavin Shimon; Cornelissen Jan J; Gramatzki Martin; Niederwieser Dietger; Russell Nigel H; Schmitz Norbert
Reduced-intensity conditioning compared with conventional allogeneic stem-cell transplantation in relapsed or refractory Hodgkin's lymphoma: an analysis from the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(3):455-62.
2008: Hudecek Michael; Bartsch Kristina; Jäkel Nadja; Heyn Simone; Pfannes Roald; Al-Ali Haifa Kathrin; Cross Michael; Pönisch Wolfram; Gerecke Ulrich; Edelmann Jeanett; Ittel Thomas; Niederwieser Dietger
Spontaneous remission of acute myeloid leukemia relapse after hematopoietic cell transplantation in a high-risk patient with 11q23/MLL abnormality.
Acta haematologica 2008;119(2):111-4.
2008: Cross Michael; Alt Rüdiger; Niederwieser Dietger
The case for a metabolic stem cell niche.
Cells, tissues, organs 2008;188(1-2):150-9.
2007: Gratwohl Alois; Baldomero Helen; Schwendener Alvin; Gratwohl Michael; Apperley Jane; Niederwieser Dietger; Frauendorfer Karl;
Predictability of hematopoietic stem cell transplantation rates.
Haematologica 2007;92(12):1679-86.
2007: Gahrton Gösta; Iacobelli Simona; Bandini Giuseppe; Björkstrand Bo; Corradini Paolo; Crawley Charles; Hegenbart Ute; Morgan Gareth; Kröger Nicolaus; Schattenberg Anton; Schönland Stefan O; Verdonck Leo F; Volin Lisa; de Witte Theo; Niederwieser Dietger;
Peripheral blood or bone marrow cells in reduced-intensity or myeloablative conditioning allogeneic HLA identical sibling donor transplantation for multiple myeloma.
Haematologica 2007;92(11):1513-8.
2007: Deininger Michael W N; Cortes Jorge; Paquette Ron; Park Byung; Hochhaus Andreas; Baccarani Michele; Stone Richard; Fischer Thomas; Kantarjian Hagop; Niederwieser Dietger; Gambacorti-Passerini Carlo; So Charlene; Gathmann Insa; Goldman John M; Smith Douglas; Druker Brian J; Guilhot François
The prognosis for patients with chronic myeloid leukemia who have clonal cytogenetic abnormalities in philadelphia chromosome-negative cells.
Cancer 2007;110(7):1509-19.
2007: Kahl Christoph; Storer Barry E; Sandmaier Brenda M; Mielcarek Marco; Maris Michael B; Blume Karl G; Niederwieser Dietger; Chauncey Thomas R; Forman Stephen J; Agura Edward; Leis Jose F; Bruno Benedetto; Langston Amelia; Pulsipher Michael A; McSweeney Peter A; Wade James C; Epner Elliot; Bo Petersen Finn; Bethge Wolfgang A; Maloney David G; Storb Rainer
Relapse risk in patients with malignant diseases given allogeneic hematopoietic cell transplantation after nonmyeloablative conditioning.
Blood 2007;110(7):2744-8.
2007: Al-Ali H K; Brand R; van Biezen A; Finke J; Boogaerts M; Fauser A A; Egeler M; Cahn J-Y; Arnold R; Biersack H; Niederwieser D; de Witte T
A retrospective comparison of autologous and unrelated donor hematopoietic cell transplantation in myelodysplastic syndrome and secondary acute myeloid leukemia: a report on behalf of the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT).
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2007;21(9):1945-51.
2007: Al-Ali H K; Wittekind C; Niederwieser D
[Complete remission of relapsed mixed cellularity Hodgkin's disease treated with rituximab]
Deutsche medizinische Wochenschrift (1946) 2007;132(33):1688-91.
2007: Bourhis Jean-Henri; Bouko Yasmina; Koscielny Serge; Bakkus Marleen; Greinix Hildegard; Derigs Gunter; Salles Gilles; Feremans Walter; Apperley Jane; Samson Diana; Björkstrand Bo; Niederwieser Dietger; Gahrton Gösta; Pico José-Luis; Goldschmidt Hartmut;
Relapse risk after autologous transplantation in patients with newly diagnosed myeloma is not related with infused tumor cell load and the outcome is not improved by CD34+ cell selection: long term follow-up of an EBMT phase III randomized study.
Haematologica 2007;92(8):1083-90.
2007: Knop S; Hebart H; Gratwohl A; Kliem C; Faul C; Holler E; Apperley J; Kolb H J; Schaefer A; Niederwieser D; Einsele H
Treatment of steroid-resistant acute GVHD with OKT3 and high-dose steroids results in better disease control and lower incidence of infectious complications when compared to high-dose steroids alone: a randomized multicenter trial by the EBMT Chronic Leukemia Working Party.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2007;21(8):1830-3.
2007: Montemurro M; Kiefer T; Schüler F; Al-Ali H K; Wolf H-H; Herbst R; Haas A; Helke K; Theilig A; Lotze C; Hirt C; Niederwieser D; Schwenke M; Krüger W H; Dölken G
Primary central nervous system lymphoma treated with high-dose methotrexate, high-dose busulfan/thiotepa, autologous stem-cell transplantation and response-adapted whole-brain radiotherapy: results of the multicenter Ostdeutsche Studiengruppe Hamato-Onkologie OSHO-53 phase II study.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2007;18(4):665-71.
2007: Crawley Charles; Iacobelli Simona; Björkstrand Bo; Apperley Jane F; Niederwieser Dietger; Gahrton Gösta
Reduced-intensity conditioning for myeloma: lower nonrelapse mortality but higher relapse rates compared with myeloablative conditioning.
Blood 2007;109(8):3588-94.
2007: Secondino Simona; Carrabba Matteo G; Pedrazzoli Paolo; Castagna Luca; Spina Francesco; Grosso Federica; Bertuzzi Alexia; Bay Jacques-Olivier; Siena Salvatore; Corradini Paolo; Niederwieser Dietger; Demirer Taner;
Reduced intensity stem cell transplantation for advanced soft tissue sarcomas in adults: a retrospective analysis of the European Group for Blood and Marrow Transplantation.
Haematologica 2007;92(3):418-20.
2007: Neumann Susanne; Schoppmeyer Konrad; Lange Thoralf; Wiedmann Marcus; Golsong Johannes; Tannapfel Andrea; Mossner Joachim; Niederwieser Dietger; Caca Karel
Wireless capsule endoscopy for diagnosis of acute intestinal graft-versus-host disease.
Gastrointestinal endoscopy 2007;65(3):403-9.
2007: Ganepola S; Gentilini C; Hilbers U; Lange T; Rieger K; Hofmann J; Maier M; Liebert U G; Niederwieser D; Engelmann E; Heilbronn R; Thiel E; Uharek L
Patients at high risk for CMV infection and disease show delayed CD8+ T-cell immune recovery after allogeneic stem cell transplantation.
Bone marrow transplantation 2007;39(5):293-9.
2007: Hochhaus Andreas; Kantarjian Hagop M; Baccarani Michele; Lipton Jeffrey H; Apperley Jane F; Druker Brian J; Facon Thierry; Goldberg Stuart L; Cervantes Francisco; Niederwieser Dietger; Silver Richard T; Stone Richard M; Hughes Timothy P; Muller Martin C; Ezzeddine Rana; Countouriotis Athena M; Shah Neil P
Dasatinib induces notable hematologic and cytogenetic responses in chronic-phase chronic myeloid leukemia after failure of imatinib therapy.
Blood 2007;109(6):2303-9.
2007: Ruutu Tapani; Barosi Giovanni; Benjamin Richard J; Clark Richard E; George James N; Gratwohl Alois; Holler Ernst; Iacobelli Massimo; Kentouche Karim; Lämmle Bernhard; Moake Joel L; Richardson Paul; Socié Gerard; Zeigler Zella; Niederwieser Dietger; Barbui Tiziano;
Diagnostic criteria for hematopoietic stem cell transplant-associated microangiopathy: results of a consensus process by an International Working Group.
Haematologica 2007;92(1):95-100.
2007: Gratwohl A; Baldomero H; Frauendorfer K; Urbano-Ispizua A; Niederwieser D;
Results of the EBMT activity survey 2005 on haematopoietic stem cell transplantation: focus on increasing use of unrelated donors.
Bone marrow transplantation 2007;39(2):71-87.
2007: Dreger P; Corradini P; Kimby E; Michallet M; Milligan D; Schetelig J; Wiktor-Jedrzejczak W; Niederwieser D; Hallek M; Montserrat E;
Indications for allogeneic stem cell transplantation in chronic lymphocytic leukemia: the EBMT transplant consensus.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2007;21(1):12-7.
2007: Renner Regina; Kauer Friederike; Treudler Regina; Niederwieser Dietger; Simon Jan C
Eosinophilic cellulitis (Wells' syndrome) in association with angioimmunoblastic lymphadenopathy.
Acta dermato-venereologica 2007;87(6):525-8.
2006: Saussele S; Adam K; Hochhaus A; Béné M C; Büchner T; Burnett A; Finazzi G; Fonatsch C; Gluckman E; Gökbuget N; Grimwade D J; Haferlach T; Hallek M; Hasford J; Hoelzer D; Ljungman P; Niederwieser D; Serve H; Simonsson B; de Witte T J; Hehlmann R;
[Clinical research at the European LeukemiaNet]
Deutsche medizinische Wochenschrift (1946) 2006;131(43):2423-6.
2006: Pfannes R; Niederwieser D
[Bone marrow puncture]
Deutsche medizinische Wochenschrift (1946) 2006;131(43):2411-3.
2006: Lange T; Pelz-Ackermann O; Burkhardt R; Niederwieser D
[Molecular monitoring: an essential component of the treatment for chronic myeloid leukemia]
Deutsche medizinische Wochenschrift (1946) 2006;131(43):2390-4.
2006: Niederwieser D; Hiddemann W
[Future-oriented hemato-oncology in times of confusion in health politics]
Deutsche medizinische Wochenschrift (1946) 2006;131(43):2385.
2006: Raida M; Heymann A C; Günther C; Niederwieser D
Role of bone morphogenetic protein 2 in the crosstalk between endothelial progenitor cells and mesenchymal stem cells.
International journal of molecular medicine 2006;18(4):735-9.
2006: Baron Frédéric; Storb Rainer; Storer Barry E; Maris Michael B; Niederwieser Dietger; Shizuru Judith A; Chauncey Thomas R; Bruno Benedetto; Forman Stephen J; McSweeney Peter A; Maziarz Richard T; Pulsipher Michael A; Agura Edward D; Wade James; Sorror Mohamed; Maloney David G; Sandmaier Brenda M
Factors associated with outcomes in allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning after failed myeloablative hematopoietic cell transplantation.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(25):4150-7.
2006: Raida M; Weiss T; Leo C; Lenz D; Tarnok A; Ameri K; Harris A L; Höckel M; Niederwieser D
Circulating endothelial progenitor cells are inversely correlated with the median oxygen tension in the tumor tissue of patients with cervical cancer.
Oncology reports 2006;16(3):597-601.
2006: Baccarani Michele; Saglio Giuseppe; Goldman John; Hochhaus Andreas; Simonsson Bengt; Appelbaum Frederick; Apperley Jane; Cervantes Francisco; Cortes Jorge; Deininger Michael; Gratwohl Alois; Guilhot François; Horowitz Mary; Hughes Timothy; Kantarjian Hagop; Larson Richard; Niederwieser Dietger; Silver Richard; Hehlmann Rudiger;
Evolving concepts in the management of chronic myeloid leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet.
Blood 2006;108(6):1809-20.
2006: Lange Thoralf; Franke Georg; Niederwieser Dietger
Parotitis associated with a parainfluenza virus type 3 infection during aplasia after unrelated allogeneic stem cell transplantation.
Leukemia & lymphoma 2006;47(8):1714-5.
2006: Martino Rodrigo; Iacobelli Simona; Brand Ronald; Jansen Thekla; van Biezen Anja; Finke Jürgen; Bacigalupo Andrea; Beelen Dietrich; Reiffers Jossy; Devergie Agnes; Alessandrino Emilie; Mufti Ghulam J; Barge Renée; Sierra Jorge; Ruutu Tapani; Boogaerts Marc; Falda Michele; Jouet Jean-Pierre; Niederwieser Dieter; de Witte Theo;
Retrospective comparison of reduced-intensity conditioning and conventional high-dose conditioning for allogeneic hematopoietic stem cell transplantation using HLA-identical sibling donors in myelodysplastic syndromes.
Blood 2006;108(3):836-46.
2006: Barkholt L; Bregni M; Remberger M; Blaise D; Peccatori J; Massenkeil G; Pedrazzoli P; Zambelli A; Bay J-O; Francois S; Martino R; Bengala C; Brune M; Lenhoff S; Porcellini A; Falda M; Siena S; Demirer T; Niederwieser D; Ringdén O;
Allogeneic haematopoietic stem cell transplantation for metastatic renal carcinoma in Europe.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2006;17(7):1134-40.
2006: Schoppmeyer K; Lange T; Wittekind C; Niederwieser D; Caca K
TIPS for veno-occlusive disease following stem cell transplantation.
Zeitschrift für Gastroenterologie 2006;44(6):483-6.
2006: de Witte Theo; Brand Ronald; van Biezen Anja; Delforge Michel; Biersack Harold; Or Reuven; Meloni Giovanna; Bandini Beppe; Sierra Jorge; Kroger Nicolaus; Gratwohl Alois; Niederwieser Dietger;
The role of stem cell source in autologous hematopoietic stem cell transplantation for patients with myelodysplastic syndromes.
Haematologica 2006;91(6):750-6.
2006: Deininger Michael; Schleuning Michael; Greinix Hilde; Sayer Herbert Gottfried; Fischer Thomas; Martinez Jesus; Maziarz Richard; Olavarria Eduardo; Verdonck Leo; Schaefer Kerstin; Boqué Conxa; Faber Edgar; Nagler Arnon; Pogliani Enrico; Russell Nigel; Volin Liisa; Schanz Urs; Doelken Gottfried; Kiehl Michael; Fauser Axel; Druker Brian; Sureda Anna; Iacobelli Simona; Brand Ronald; Krahl Rainer; Lange Thoralf; Hochhaus Andreas; Gratwohl Alois; Kolb Hans; Niederwieser Dietger;
The effect of prior exposure to imatinib on transplant-related mortality.
Haematologica 2006;91(4):452-9.
2006: Gratwohl Alois; Brand Ronald; Apperley Jane; Crawley Charles; Ruutu Tapani; Corradini Paolo; Carreras Enric; Devergie Agnes; Guglielmi Cesare; Kolb Hans-Jochen; Niederwieser Dietger;
Allogeneic hematopoietic stem cell transplantation for chronic myeloid leukemia in Europe 2006: transplant activity, long-term data and current results. An analysis by the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT).
Haematologica 2006;91(4):513-21.
2006: Pönisch W; Mitrou P S; Merkle K; Herold M; Assmann M; Wilhelm G; Dachselt K; Richter P; Schirmer V; Schulze A; Subert R; Harksel B; Grobe N; Stelzer E; Schulze M; Bittrich A; Freund M; Pasold R; Friedrich Th; Helbig W; Niederwieser D;
Treatment of bendamustine and prednisone in patients with newly diagnosed multiple myeloma results in superior complete response rate, prolonged time to treatment failure and improved quality of life compared to treatment with melphalan and prednisone--a randomized phase III study of the East German Study Group of Hematology and Oncology (OSHO).
Journal of cancer research and clinical oncology 2006;132(4):205-12.
2006: Pönisch W; Niederwieser D
[Late effects after chemotherapy]
Der Internist 2006;47(3):266-8, 270-72.
2006: Ljungman P; Urbano-Ispizua A; Cavazzana-Calvo M; Demirer T; Dini G; Einsele H; Gratwohl A; Madrigal A; Niederwieser D; Passweg J; Rocha V; Saccardi R; Schouten H; Schmitz N; Socie G; Sureda A; Apperley J;
Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: definitions and current practice in Europe.
Bone marrow transplantation 2006;37(5):439-49.
2006: Schönland Stefan O; Lokhorst Henk; Buzyn Agnes; Leblond Veronique; Hegenbart Ute; Bandini Giuseppe; Campbell Andrew; Carreras Enric; Ferrant Augustin; Grommisch Leanthe; Jacobs Peter; Kröger Nicolaus; La Nasa Giorgio; Russell Nigel; Zachee Pierre; Goldschmidt Hartmut; Iacobelli Simona; Niederwieser Dietger; Gahrton Gösta;
Allogeneic and syngeneic hematopoietic cell transplantation in patients with amyloid light-chain amyloidosis: a report from the European Group for Blood and Marrow Transplantation.
Blood 2006;107(6):2578-84.
2006: Herold M; Schulze A; Niederwieser D; Franke A; Fricke H J; Richter P; Freund M; Ismer B; Dachselt K; Boewer C; Schirmer V; Weniger J; Pasold R; Winkelmann C; Klinkenstein C; Schulze M; Arzberger H; Bremer K; Hahnfeld S; Schwarzer A; Müller C; Müller Chr;
Bendamustine, vincristine and prednisone (BOP) versus cyclophosphamide, vincristine and prednisone (COP) in advanced indolent non-Hodgkin's lymphoma and mantle cell lymphoma: results of a randomised phase III trial (OSHO# 19).
Journal of cancer research and clinical oncology 2006;132(2):105-12.
2006: Hegenbart Ute; Niederwieser Dietger; Sandmaier Brenda M; Maris Michael B; Shizuru Judith A; Greinix Hildegard; Cordonnier Catherine; Rio Bernard; Gratwohl Alois; Lange Thoralf; Al-Ali Haifa; Storer Barry; Maloney David; McSweeney Peter; Chauncey Thomas; Agura Ed; Bruno Benedetto; Maziarz Richard T; Petersen Finn; Storb Rainer
Treatment for acute myelogenous leukemia by low-dose, total-body, irradiation-based conditioning and hematopoietic cell transplantation from related and unrelated donors.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(3):444-53.
2006: Kröger N; Brand R; van Biezen A; Cahn J-Y; Slavin S; Blaise D; Sierra J; Zander A; Niederwieser D; de Witte T;
Autologous stem cell transplantation for therapy-related acute myeloid leukemia and myelodysplastic syndrome.
Bone marrow transplantation 2006;37(2):183-9.
2006: Then Bergh Florian; Niklas Alexander; Strauss Angelika; von Ahsen Nicolas; Niederwieser Dietger; Schwarz Johannes; Wagner Armin; Al-Ali Haifa K
Rapid progression of Myelodysplastic syndrome to acute myeloid leukemia on sequential azathioprine, IFN-beta and copolymer-1 in a patient with multiple sclerosis.
Acta haematologica 2006;116(3):207-10.
2006: Niederwieser Dietger; Lange Thoralf; Cross Michael; Basara Nadesda; Al-Ali Haifa
Reduced intensity conditioning (RIC) haematopoietic cell transplants in elderly patients with AML.
Best practice & research. Clinical haematology 2006;19(4):825-38.
2005: Aoudjhane M; Labopin M; Gorin N C; Shimoni A; Ruutu T; Kolb H-J; Frassoni F; Boiron J M; Yin J L; Finke J; Shouten H; Blaise D; Falda M; Fauser A A; Esteve J; Polge E; Slavin S; Niederwieser D; Nagler A; Rocha V;
Comparative outcome of reduced intensity and myeloablative conditioning regimen in HLA identical sibling allogeneic haematopoietic stem cell transplantation for patients older than 50 years of age with acute myeloblastic leukaemia: a retrospective survey from the Acute Leukemia Working Party (ALWP) of the European group for Blood and Marrow Transplantation (EBMT).
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2005;19(12):2304-12.
2005: Peccatori Jacopo; Barkholt Lisbeth; Demirer Tanner; Sormani Maria Pia; Bruzzi Paolo; Ciceri Fabio; Zambelli Alberto; Da Prada Gian Antonio; Pedrazzoli Paolo; Siena Salvatore; Massenkeil Gero; Martino Rodrigo; Lenhoff Stig; Corradini Paolo; Rosti Giovanni; Ringden Olle; Bregni Marco; Niederwieser Dietger;
Prognostic factors for survival in patients with advanced renal cell carcinoma undergoing nonmyeloablative allogeneic stem cell transplantation.
Cancer 2005;104(10):2099-103.
2005: Niederwieser Dietger; Gentilini Chiara; Hegenbart Ute; Lange Thoralf; Becker Cornelia; Wang Song-Yau; Bartsch Kristina; Pönisch Wolfram; Raida Martin; Al-Ali Haifa
Allogeneic hematopoietic cell transplantation (HCT) following reduced-intensity conditioning in patients with acute leukemias.
Critical reviews in oncology/hematology 2005;56(2):275-81.
2005: Knop S; Hebart H; Gscheidle H; Holler E; Kolb H-J; Niederwieser D; Einsele H
OKT3 muromonab as second-line and subsequent treatment in recipients of stem cell allografts with steroid-resistant acute graft-versus-host disease.
Bone marrow transplantation 2005;36(9):831-7.
2005: Gratwohl A; Brand R; Frassoni F; Rocha V; Niederwieser D; Reusser P; Einsele H; Cordonnier C;
Cause of death after allogeneic haematopoietic stem cell transplantation (HSCT) in early leukaemias: an EBMT analysis of lethal infectious complications and changes over calendar time.
Bone marrow transplantation 2005;36(9):757-69.
2005: Raida Martin; Clement Joachim H; Leek Russell D; Ameri Kurosh; Bicknell Roy; Niederwieser Dietger; Harris Adrian L
Bone morphogenetic protein 2 (BMP-2) and induction of tumor angiogenesis.
Journal of cancer research and clinical oncology 2005;131(11):741-50.
2005: Crawley Charles; Szydlo Richard; Lalancette Marc; Bacigalupo Andrea; Lange Andrzej; Brune Mats; Juliusson Gunnar; Nagler Arnon; Gratwohl Alois; Passweg Jakob; Komarnicki Mieczyslaw; Vitek Antonin; Mayer Jiri; Zander Axel; Sierra Jorge; Rambaldi Alessandro; Ringden Olle; Niederwieser Dietger; Apperley Jane F;
Outcomes of reduced-intensity transplantation for chronic myeloid leukemia: an analysis of prognostic factors from the Chronic Leukemia Working Party of the EBMT.
Blood 2005;106(9):2969-76.
2005: Windrum P; Morris T C M; Drake M B; Niederwieser D; Ruutu T;
Variation in dimethyl sulfoxide use in stem cell transplantation: a survey of EBMT centres.
Bone marrow transplantation 2005;36(7):601-3.
2005: Willis Stephanie G; Lange Thoralf; Demehri Shadmehr; Otto Sandra; Crossman Lucy; Niederwieser Dietger; Stoffregen Eric P; McWeeney Shannon; Kovacs Ines; Park Byung; Druker Brian J; Deininger Michael W
High-sensitivity detection of BCR-ABL kinase domain mutations in imatinib-naive patients: correlation with clonal cytogenetic evolution but not response to therapy.
Blood 2005;106(6):2128-37.
2005: Hertenstein Bernd; Hambach Lothar; Bacigalupo Andrea; Schmitz Norbert; McCann Shaun; Slavin Shimon; Gratwohl Alois; Ferrant Augustin; Elmaagacli Ahmet; Schwertfeger Rainer; Locasciulli Anna; Zander Axel; Bornhäuser Martin; Niederwieser Dietger; Ruutu Tapani;
Development of leukemia in donor cells after allogeneic stem cell transplantation--a survey of the European Group for Blood and Marrow Transplantation (EBMT).
Haematologica 2005;90(7):969-75.
2005: Lange T; Bumm T; Mueller M; Otto S; Al-Ali H-K; Grommisch L; Musiol S; Franke C; Krahl R; Niederwieser D; Deininger M W N
Durability of molecular remission in chronic myeloid leukemia patients treated with imatinib vs allogeneic stem cell transplantation.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2005;19(7):1262-5.
2005: Dreger P; Brand R; Milligan D; Corradini P; Finke J; Lambertenghi Deliliers G; Martino R; Russell N; van Biezen A; Michallet M; Niederwieser D;
Reduced-intensity conditioning lowers treatment-related mortality of allogeneic stem cell transplantation for chronic lymphocytic leukemia: a population-matched analysis.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2005;19(6):1029-33.
2005: Kerbauy F R; Storb R; Hegenbart U; Gooley T; Shizuru J; Al-Ali H K; Radich J P; Maloney D G; Agura E; Bruno B; Epner E M; Chauncey T R; Blume K G; Niederwieser D; Sandmaier B M
Hematopoietic cell transplantation from HLA-identical sibling donors after low-dose radiation-based conditioning for treatment of CML.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2005;19(6):990-7.
2005: Crawley Charles; Lalancette Marc; Szydlo Richard; Gilleece Maria; Peggs Karl; Mackinnon Stephen; Juliusson Gunnar; Ahlberg Lucia; Nagler Arnon; Shimoni Avichai; Sureda Anna; Boiron Jean-Michel; Einsele Herman; Chopra Rajesh; Carella Angelo; Cavenagh Jamie; Gratwohl Alois; Garban Frederic; Zander Axel; Björkstrand Bo; Niederwieser Dietger; Gahrton Gösta; Apperley Jane F;
Outcomes for reduced-intensity allogeneic transplantation for multiple myeloma: an analysis of prognostic factors from the Chronic Leukaemia Working Party of the EBMT.
Blood 2005;105(11):4532-9.
2005: Mielcarek Marco; Burroughs Lauri; Leisenring Wendy; Diaconescu Razvan; Martin Paul J; Sandmaier Brenda M; Maloney David G; Maris Michael B; Chauncey Thomas R; Shizuru Judith A; Blume Karl G; Hegenbart Ute; Niederwieser Dietger; Forman Stephen; Bruno Benedetto; Woolfrey Ann; Storb Rainer
Prognostic relevance of 'early-onset' graft-versus-host disease following non-myeloablative haematopoietic cell transplantation.
British journal of haematology 2005;129(3):381-91.
2005: Crossman Lucy C; Mori Motomi; Hsieh Yi-Ching; Lange Thoralf; Paschka Peter; Harrington Christina A; Krohn Knut; Niederwieser Dietger W; Hehlmann Rüdiger; Hochhaus Andreas; Druker Brian J; Deininger Michael W N
In chronic myeloid leukemia white cells from cytogenetic responders and non-responders to imatinib have very similar gene expression signatures.
Haematologica 2005;90(4):459-64.
2005: Banning U; Lange T; Krahl R; Mauz-Körholz C; Krutmann J; Niederwieser D; Körholz D
Prognostic value of T-1 cell numbers prior to allogeneic stem cell transplantation in patients with severe graft-versus-host disease.
Bone marrow transplantation 2005;35(7):691-7.
2005: Gahrton G; Iacobelli S; Apperley J; Bandini G; Björkstrand B; Bladé J; Boiron J M; Cavo M; Cornelissen J; Corradini P; Kröger N; Ljungman P; Michallet M; Russell N H; Samson D; Schattenberg A; Sirohi B; Verdonck L F; Volin L; Zander A; Niederwieser D
The impact of donor gender on outcome of allogeneic hematopoietic stem cell transplantation for multiple myeloma: reduced relapse risk in female to male transplants.
Bone marrow transplantation 2005;35(6):609-17.
2005: Wetzig T; Sticherling M; Simon J-C; Hegenbart U; Niederwieser D; Al-Ali H K
Medium dose long-wavelength ultraviolet A (UVA1) phototherapy for the treatment of acute and chronic graft-versus-host disease of the skin.
Bone marrow transplantation 2005;35(5):515-9.
2005: Ruutu T; Corradini P; Gratwohl A; Holler E; Apperley J; Dini G; Rocha V; Schmitz N; Socié G; Niederwieser D
Use of intrathecal prophylaxis in allogeneic haematopoietic stem cell transplantation for malignant blood diseases: a survey of the European Group for Blood and Marrow Transplantation (EBMT).
Bone marrow transplantation 2005;35(2):121-4.
2005: Kröger N; Brand R; van Biezen A; Bron D; Blaise D; Hellström-Lindberg E; Gahrton G; Powles R; Littlewood T; Chapuis B; Zander A; Koza V; Niederwieser D; de Witte T;
Stem cell transplantation from identical twins in patients with myelodysplastic syndromes.
Bone marrow transplantation 2005;35(1):37-43.
2005: Gahrton G; Iacobelli S; Björkstrand B; Bourhis J; Corradini P; Crawley C; Morris C; Niederwieser D;
Role of stem cell transplantation in myeloma.
Hematology (Amsterdam, Netherlands) 2005;10 Suppl 1():127-8.
2004: Knauf Wolfgang; Rieger Kathrin; Blau Wolfgang; Hegenbart Ute; Von Gruenhagen Ulrich; Niederwieser Dietger; Thiel Eckhard
Remission induction using alemtuzumab can permit chemotherapy-refractory chronic lymphocytic leukemia (CLL) patients to undergo allogeneic stem cell transplantation.
Leukemia & lymphoma 2004;45(12):2455-8.
2004: Kircher Brigitte; Hack C Erik; Dickinson Anne M; Wang Xiao N; Oudshoorn Machteld; Sachs Annemarie; Wolbink Angela; Niederwieser Dietger; Eibl Günther J; van Houwelingen Hans C; Goulmy Els
Towards functional transplant donor matching by measurement of granzyme A and granzyme B production levels.
Journal of immunological methods 2004;293(1-2):51-9.
2004: Niederwieser D; Gentilini C; Hegenbart U; Lange T; Moosmann P; Pönisch W; Al-Ali H; Raida M; Ljungman P; Tyndall A; Urbano-Ispizua A; Lazarus H M; Gratwohl A
Transmission of donor illness by stem cell transplantation: should screening be different in older donors?
Bone marrow transplantation 2004;34(8):657-65.
2004: Schlenk R F; Benner A; Krauter J; Büchner T; Sauerland C; Ehninger G; Schaich M; Mohr B; Niederwieser D; Krahl R; Pasold R; Döhner K; Ganser A; Döhner H; Heil G
Individual patient data-based meta-analysis of patients aged 16 to 60 years with core binding factor acute myeloid leukemia: a survey of the German Acute Myeloid Leukemia Intergroup.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(18):3741-50.
2004: Lange T; Deininger M; Brand R; Hegenbart U; Al-Ali H; Krahl R; Poenisch W; Uharek L; Leiblein S; Gentilini C; Petersdorf E; Storb R F; Niederwieser D
BCR-ABL transcripts are early predictors for hematological relapse in chronic myeloid leukemia after hematopoietic cell transplantation with reduced intensity conditioning.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2004;18(9):1468-75.
2004: Kircher Brigitte; Niederwieser Dietger; Gächter Anne; Lätzer Karla; Eibl Günther; Gastl Günther; Nachbaur David
No predictive value of cytotoxic or helper T-cell precursor frequencies for outcome when analyzed from the graft after stem cell transplantation.
Annals of hematology 2004;83(9):566-72.
2004: Schmid C; Schleuning M; Aschan J; Ringdén O; Hahn J; Holler E; Hegenbart U; Niederwieser D; Dugas M; Ledderose G; Kolb H-J
Low-dose ARAC, donor cells, and GM-CSF for treatment of recurrent acute myeloid leukemia after allogeneic stem cell transplantation.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2004;18(8):1430-3.
2004: Tiercy J-M; Passweg J; van Biezen A; Zander A; Kröger N; Gratwohl A; Chapuis B; Helg C; Brinch L; Cornelissen J; Oudshoorn M; Ruutu T; Volin L; Niederwieser D; Roosnek E;
Isolated HLA-C mismatches in unrelated donor transplantation for CML.
Bone marrow transplantation 2004;34(3):249-55.
2004: Preiss Rainer; Baumann Frank; Stefanovic Dragan; Niemeyer Ulf; Pönisch Wolfgang; Niederwieser Dietger
Investigations on the pharmacokinetics of trofosfamide and its metabolites-first report of 4-hydroxy-trofosfamide kinetics in humans.
Cancer chemotherapy and pharmacology 2004;53(6):496-502.
2004: Büchner Thomas; Döhner Hartmut; Ehninger Gerhard; Ganser Arnold; Niederwieser Dietger; Hasford Joerg
Cross-trial networking in AML: a step forward rather than corner cutting.
Leukemia research 2004;28(6):649-50.
2004: Morris C; Iacobelli S; Brand R; Bjorkstrand B; Drake M; Niederwieser D; Gahrton G;
Benefit and timing of second transplantations in multiple myeloma: clinical findings and methodological limitations in a European Group for Blood and Marrow Transplantation registry study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(9):1674-81.
2004: Hehlmann R; Berger U; Aul C; Büchner Th; Döhner H; Ehninger G; Ganser A; Gökbuget N; Hoelzer D; Uberla K; Gassmann W; Ludwig W D; Rieder H; Kneba M; Hochhaus A; Reiter A; Hiddemann W; Ottmann O G; Germing U; Adelhard K; Dugas M; Dirschedl P; Messerer D; Böhme A; Harrison-Neu E; Griesshammer M; Kienast J; Kolb H J; Ho A D; Hallek M; Neubauer A; Schlegelberger B; Niederwieser D; Heil G; Müller T; Hasford J
The German competence network 'Acute and chronic leukemias'.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2004;18(4):665-9.
2004: Bethge Wolfgang A; Hegenbart Ute; Stuart Monic J; Storer Barry E; Maris Michael B; Flowers Mary E D; Maloney David G; Chauncey Thomas; Bruno Benedetto; Agura Ed; Forman Stephen J; Blume Karl G; Niederwieser Dietger; Storb Rainer; Sandmaier Brenda M
Adoptive immunotherapy with donor lymphocyte infusions after allogeneic hematopoietic cell transplantation following nonmyeloablative conditioning.
Blood 2004;103(3):790-5.
2004: Lange Thoralf; Bumm Thomas; Otto Sandra; Al-Ali Haifa-Kathrin; Kovacs Ines; Krug Daniela; Köhler Thomas; Krahl Rainer; Niederwieser Dietger; Deininger Michael W N
Quantitative reverse transcription polymerase chain reaction should not replace conventional cytogenetics for monitoring patients with chronic myeloid leukemia during early phase of imatinib therapy.
Haematologica 2004;89(1):49-57.
2004: Al-Ali Haifa-Kathrin; Heinrich Michael Charles; Lange Thoralf; Krahl Rainer; Mueller Matthias; Müller Christel; Niederwieser Dietger; Druker Brian James; Deininger Michael Werner Nikolaus
High incidence of BCR-ABL kinase domain mutations and absence of mutations of the PDGFR and KIT activation loops in CML patients with secondary resistance to imatinib.
The hematology journal : the official journal of the European Haematology Association / EHA 2004;5(1):55-60.
2003: Ljungman Per; Brand Ronald; Einsele Hermann; Frassoni Francesco; Niederwieser Dietger; Cordonnier Catherine
Donor CMV serologic status and outcome of CMV-seropositive recipients after unrelated donor stem cell transplantation: an EBMT megafile analysis.
Blood 2003;102(13):4255-60.
2003: Hegenbart U; Niederwieser D; Forman S; Holler E; Leiblein S; Johnston L; Pönisch W; Epner E; Witherspoon R; Blume K; Storb R
Hematopoietic cell transplantation from related and unrelated donors after minimal conditioning as a curative treatment modality for severe paroxysmal nocturnal hemoglobinuria.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2003;9(11):689-97.
2003: Lange Thoralf; Niederwieser Dietger W; Deininger Michael W N
Residual disease in chronic myeloid leukemia after induction of molecular remission.
The New England journal of medicine 2003;349(15):1483-4.
2003: Reinhold U; Hennig E; Leiblein S; Niederwieser D; Deininger M W N
FISH for BCR-ABL on interphases of peripheral blood neutrophils but not of unselected white cells correlates with bone marrow cytogenetics in CML patients treated with imatinib.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2003;17(10):1925-9.
2003: Einsele Hermann; Bertz Hartmut; Beyer Jörg; Kiehl Michael G; Runde Volker; Kolb Hans-Jochen; Holler Ernst; Beck Robert; Schwerdfeger Rainer; Schumacher Ulrike; Hebart Holger; Martin Hans; Kienast Joachim; Ullmann Andrew J; Maschmeyer Georg; Krüger William; Niederwieser Dietger; Link Hartmut; Schmidt Christian A; Oettle Helmut; Klingebiel Thomas;
Infectious complications after allogeneic stem cell transplantation: epidemiology and interventional therapy strategies--guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO).
Annals of hematology 2003;82 Suppl 2():S175-85.
2003: Olavarria E; Ottmann O G; Deininger M; Clark R E; Bandini G; Byrne J; Lipton J; Vitek A; Michallet M; Siegert W; Ullmann A; Wassmann B; Niederwieser D; Fischer T;
Response to imatinib in patients who relapse after allogeneic stem cell transplantation for chronic myeloid leukemia.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2003;17(9):1707-12.
2003: Maris Michael B; Niederwieser Dietger; Sandmaier Brenda M; Storer Barry; Stuart Monic; Maloney David; Petersdorf Effie; McSweeney Peter; Pulsipher Michael; Woolfrey Ann; Chauncey Thomas; Agura Ed; Heimfeld Shelly; Slattery John; Hegenbart Ute; Anasetti Claudio; Blume Karl; Storb Rainer
HLA-matched unrelated donor hematopoietic cell transplantation after nonmyeloablative conditioning for patients with hematologic malignancies.
Blood 2003;102(6):2021-30.
2003: Huntly Brian J P; Guilhot Francois; Reid Alistair G; Vassiliou George; Hennig Evelin; Franke Christina; Byrne Jennie; Brizard Andre; Niederwieser Dietger; Freeman-Edward Julie; Cuthbert Gavin; Bown Nick; Clark Richard E; Nacheva Elizabeth P; Green Anthony R; Deininger Michael W N
Imatinib improves but may not fully reverse the poor prognosis of patients with CML with derivative chromosome 9 deletions.
Blood 2003;102(6):2205-12.
2003: Cwynarski Kate; Roberts Irene A G; Iacobelli Simona; van Biezen Anja; Brand Ronald; Devergie Agnes; Vossen Jaak M; Aljurf Mahmoud; Arcese William; Locatelli Franco; Dini Giorgio; Niethammer Dietrich; Niederwieser Dietger; Apperley Jane F;
Stem cell transplantation for chronic myeloid leukemia in children.
Blood 2003;102(4):1224-31.
2003: Bredt M; Schönfeld G; Kleeberger W; König E; Kröning H; Kettner E; Al-Ali H K; Niederwieser D; Kreipe H
Late-onset Epstein-Barr virus (EBV)-negative extranodal B-precursor lymphoblastic lymphoma of donor origin after hematopoietic stem cell transplantation (HSCT).
Bone marrow transplantation 2003;31(11):1071-2.
2003: Gratwohl A; Baldomero H; Passweg J; Frassoni F; Niederwieser D; Schmitz N; Urbano-Ispizua A;
Hematopoietic stem cell transplantation for hematological malignancies in Europe.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2003;17(5):941-59.
2003: Dreger P; Brand R; Hansz J; Milligan D; Corradini P; Finke J; Deliliers G L; Martino R; Russell N; Van Biezen A; Michallet M; Niederwieser D;
Treatment-related mortality and graft-versus-leukemia activity after allogeneic stem cell transplantation for chronic lymphocytic leukemia using intensity-reduced conditioning.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2003;17(5):841-8.
2003: Feinstein Lyle C; Sandmaier Brenda M; Maloney David G; Maris Michael B; Gooley Theodore A; Chauncey Thomas R; Hegenbart Ute; McSweeney Peter A; Stuart Monic J; Forman Stephen J; Agura Edward A; Pulsipher Michael A; Blume Karl G; Niederwieser Dietger W; Storb Rainer F
Allografting after nonmyeloablative conditioning as a treatment after a failed conventional hematopoietic cell transplant.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2003;9(4):266-72.
2003: Bumm Thomas; Müller Christel; Al-Ali Haifa-Kathrin; Krohn Knut; Shepherd Patricia; Schmidt Erika; Leiblein Sabine; Franke Christina; Hennig Evelin; Friedrich Thomas; Krahl Reiner; Niederwieser Dietger; Deininger Michael W N
Emergence of clonal cytogenetic abnormalities in Ph- cells in some CML patients in cytogenetic remission to imatinib but restoration of polyclonal hematopoiesis in the majority.
Blood 2003;101(5):1941-9.
2003: Lange Thoralf; Günther Christine; Köhler Thomas; Krahl Rainer; Musiol Scarlet; Leiblein Sabine; Al-Ali Haifa-Kathrin; van Hoomissen Iris; Niederwieser Dietger; Deininger Michael W N
High levels of BAX, low levels of MRP-1, and high platelets are independent predictors of response to imatinib in myeloid blast crisis of CML.
Blood 2003;101(6):2152-5.
2003: Hoheisel G; Lange S; Winkler J; Rodloff A C; Liebert U G; Niederwieser D; Schauer J; Engelmann L
[Nosocomial pneumonias in haematological malignancies in the medical intensive care unit]
Pneumologie (Stuttgart, Germany) 2003;57(2):73-7.
2003: Niederwieser Dietger; Maris Michael; Shizuru Judith A; Petersdorf Effie; Hegenbart Ute; Sandmaier Brenda M; Maloney David G; Storer Barry; Lange Thoralf; Chauncey Thomas; Deininger Michael; Pönisch Wolfram; Anasetti Claudio; Woolfrey Ann; Little Marie-Terese; Blume Karl G; McSweeney Peter A; Storb Rainer F
Low-dose total body irradiation (TBI) and fludarabine followed by hematopoietic cell transplantation (HCT) from HLA-matched or mismatched unrelated donors and postgrafting immunosuppression with cyclosporine and mycophenolate mofetil (MMF) can induce durable complete chimerism and sustained remissions in patients with hematological diseases.
Blood 2003;101(4):1620-9.
2003: Feinstein Lyle C; Sandmaier Brenda M; Hegenbart Ute; McSweeney Peter A; Maloney David G; Gooley Theodore A; Maris Michael B; Chauncey Thomas R; Bruno Benedetto; Appelbaum Frederick R; Niederwieser Dietger W; Storb Rainer F
Non-myeloablative allografting from human leucocyte antigen-identical sibling donors for treatment of acute myeloid leukaemia in first complete remission.
British journal of haematology 2003;120(2):281-8.
2002: Gratwohl Alois; Brand Ronald; Apperley Jane; Biezen Av Anja v; Bandini Giuseppe; Devergie Agnes; Schattenberg Anton; Frassoni Francesco; Guglielmi Cesare; Iacobelli Simona; Michallet Mauricette; Kolb Hans-Jochen; Ruutu Tapani; Niederwieser Dietger;
Graft-versus-host disease and outcome in HLA-identical sibling transplantations for chronic myeloid leukemia.
Blood 2002;100(12):3877-86.
2002: Niederwieser D
[Allogeneic hematopoetic cell transplantation in patients with solid tumors - Pro]
Deutsche medizinische Wochenschrift (1946) 2002;127(42):2214.
2002: Ruutu Tapani; Hermans Jo; Niederwieser Dietger; Gratwohl Alois; Kiehl Michael; Volin Liisa; Bertz Harmut; Ljungman Per; Spence David; Verdonck Leo F; Prentice H Grant; Bosi Alberto; Du Toit Cecile E; Brinch Lorentz; Apperley Jane F;
Thrombotic thrombocytopenic purpura after allogeneic stem cell transplantation: a survey of the European Group for Blood and Marrow Transplantation (EBMT).
British journal of haematology 2002;118(4):1112-9.
2002: Olavarria Eduardo; Reiffers Josy; Boque Concha; Sureda Ana; Meloni Giovanna; Michallet Mauricette; Clark Richard E; Blaise Didier; Carella Angelo M; Cahn Jean-Yves; Jouet Jean P; Rizzoli Vittorio; Van Biezen Anja; Gratwohl Alois; Goldman John M; Niederwieser Dietger; Apperley Jane F
The post-transplant cytogenetic response to interferon is a major determinant of survival after autologous stem cell transplantation for chronic myeloid leukaemia in chronic phase.
British journal of haematology 2002;118(3):762-70.
2002: Kircher Brigitte; Eibl Günther; Enrich Barbara; Lätzer Karla; Herold Manfred; Niederwieser Dietger
The role of L-alanyl-L-glutamine in the immune response in vitro.
Wiener klinische Wochenschrift 2002;114(15-16):702-8.
2002: Pönisch Wolfram; Niederwieser Dietger
Bendamustine in the treatment of multiple myeloma: results and future perspectives.
Seminars in oncology 2002;29(4 Suppl 13):23-6.
2002: Al-Ali Haifa-Kathria; Leiblein Sabine; Kovacs Ines; Hennig Evelin; Niederwieser Dietger; Deininger Michael W N
CML with an e1a3 BCR-ABL fusion: rare, benign, and a potential diagnostic pitfall.
Blood 2002;100(3):1092-3.
2002: Müller Christel; Hennig Evelin; Franke Christina; Krahl Rainer; Leiblein Sabine; Niederwieser Dietger; Deininger Michael W N
The BCR/ABL-extra signal fluorescence in situ hybridization system reliably detects deletions upstream of the ABL locus: implications for reporting of results and followup of chronic myelogenous leukemia patients.
Cancer genetics and cytogenetics 2002;136(2):149-50.
2002: Kröger Nicolaus; Zabelina Tatjana; Guardiola Philipe; Runde Volker; Sierra Jorge; Van Biezen Anja; Niederwieser Dietger; Zander Axel R; De Witte Theo
Allogeneic stem cell transplantation of adult chronic myelomonocytic leukaemia. A report on behalf of the Chronic Leukaemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT).
British journal of haematology 2002;118(1):67-73.
2002: Guglielmi Cesare; Arcese William; Dazzi Francesco; Brand Ronald; Bunjes Donald; Verdonck Leo F; Schattenberg Anton; Kolb Hans-Jochem; Ljungman Per; Devergie Agnes; Bacigalupo Andrea; Gomez Marta; Michallet Mauricette; Elmaagacli Ahmet; Gratwohl Alois; Apperley Jane; Niederwieser Dietger
Donor lymphocyte infusion for relapsed chronic myelogenous leukemia: prognostic relevance of the initial cell dose.
Blood 2002;100(2):397-405.
2002: Greinix Hildegard T; Nachbaur David; Krieger Otto; Eibl Margit; Knöbl Paul; Kalhs Peter; Lutz Dieter; Linkesch Werner; Niederwieser Dietger; Hinterberger Wolfgang; Lechner Klaus; Rosenmayr Agathe; Gritsch Beate
Factors affecting long-term outcome after allogeneic haematopoietic stem cell transplantation for acute myelogenous leukaemia: a retrospective study of 172 adult patients reported to the Austrian Stem Cell Transplantation Registry.
British journal of haematology 2002;117(4):914-23.
2002: Guardiola Philippe; Runde Volker; Bacigalupo Andrea; Ruutu Tapani; Locatelli Franco; Boogaerts Marc A; Pagliuca Antonio; Cornelissen Jan J; Schouten Harry C; Carreras Enric; Finke Jürgen; van Biezen Anja; Brand Ronald; Niederwieser Dietger; Gluckman Eliane; de Witte Theo M;
Retrospective comparison of bone marrow and granulocyte colony-stimulating factor-mobilized peripheral blood progenitor cells for allogeneic stem cell transplantation using HLA identical sibling donors in myelodysplastic syndromes.
Blood 2002;99(12):4370-8.
2002: Urbano-Ispizua A; Schmitz N; de Witte T; Frassoni F; Rosti G; Schrezenmeier H; Gluckman E; Friedrich W; Cordonnier C; Socie G; Tyndall A; Niethammer D; Ljungman P; Gratwohl A; Apperley J; Niederwieser D; Bacigalupo A;
Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: definitions and current practice in Europe.
Bone marrow transplantation 2002;29(8):639-46.
2002: Mielcarek Marco; Sandmaier Brenda M; Maloney David G; Maris Michael; McSweeney Peter A; Woolfrey Ann; Chauncey Thomas; Feinstein Lyle; Niederwieser Dietger; Blume Karl G; Forman Stephen; Torok-Storb Beverly; Storb Rainer
Nonmyeloablative hematopoietic cell transplantation: status quo and future perspectives.
Journal of clinical immunology 2002;22(2):70-4.
2002: Reid Alistair G; Huntly Brian J P; Hennig Eveline; Niederwieser Dietger; Campbell Lynda J; Bown Nick; Telford Nick; Walker Helen; Grace Colin D; Deininger Michael W; Green Anthony R; Nacheva Elisabeth P
Deletions of the derivative chromosome 9 do not account for the poor prognosis associated with Philadelphia-positive acute lymphoblastic leukemia.
Blood 2002;99(6):2274-5.
2002: Mantovani Luisa; Hasenclever Dirk; Krahl Rainer; Pönisch Wolfram; Herold Michael; Pasold Rita; Fiedler Friedrich; Dölken Gottfried; Kämpfe Dietrich; Schmoll Hans Joachim; Súbert Rita; Kubel Martin; Niederwieser Dietger; Helbig Werner;
Intermediate-dose cytarabine treatment delivered at moderate infusion rates for de novo acute myeloid leukemia-results of a phase I-II study.
Leukemia & lymphoma 2002;43(2):265-74.
2002: Kantarjian Hagop; Sawyers Charles; Hochhaus Andreas; Guilhot Francois; Schiffer Charles; Gambacorti-Passerini Carlo; Niederwieser Dietger; Resta Debra; Capdeville Renaud; Zoellner Ulrike; Talpaz Moshe; Druker Brian; Goldman John; O'Brien Stephen G; Russell Nigel; Fischer Thomas; Ottmann Oliver; Cony-Makhoul Pascale; Facon Thierry; Stone Richard; Miller Carole; Tallman Martin; Brown Randy; Schuster Michael; Loughran Thomas; Gratwohl Alois; Mandelli Franco; Saglio Giuseppe; Lazzarino Mario; Russo Domenico; Baccarani Michele; Morra Enrica;
Hematologic and cytogenetic responses to imatinib mesylate in chronic myelogenous leukemia.
The New England journal of medicine 2002;346(9):645-52.
2002: Köhler T; Schill C; Deininger M W; Krahl R; Borchert S; Hasenclever D; Leiblein S; Wagner O; Niederwieser D
High Bad and Bax mRNA expression correlate with negative outcome in acute myeloid leukemia (AML).
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2002;16(1):22-9.
2002: Deininger Michael; Niederwieser Dietger
[Molecular therapy of chronic myeloid leukemia--a new era in the treatment of malignant diseases]
Medizinische Klinik (Munich, Germany : 1983) 2002;97 Suppl 1():1.
2002: Nenoff Pietro; Kliem Constanze; Mittag Matthias; Horn Lars-Christian; Niederwieser Dietger; Haustein Uwe-Frithjof
Secondary cutaneous aspergillosis due to Aspergillus flavus in an acute myeloid leukaemia patient following stem cell transplantation.
European journal of dermatology : EJD 2002;12(1):93-8.
2001: Ottinger H D; Müller C R; Goldmann S F; Albert E; Arnold R; Beelen D W; Blasczyk R; Bunjes D; Casper J; Ebell W; Ehninger G; Eiermann T; Einsele H; Fauser A; Ferencik S; Finke J; Hertenstein B; Heyll A; Klingebiel T; Knipper A; Kremens B; Kolb H J; Kolbe K; Lenartz E; Lindemann M; Müller C A; Mytilineos J; Niederwieser D; Runde V; Sayer H; Schaefer U W; Schmitz N; Schröder S; Schulze-Rath R; Schwerdtfeger R; Siegert W; Thiele B; Zander A R; Grosse-Wilde H
Second German consensus on immunogenetic donor search for allotransplantation of hematopoietic stem cells.
Annals of hematology 2001;80(12):706-14.
2001: de Witte T; Pikkemaat F; Hermans J; van Biezen A; Mackinnan S; Cornelissen J; Gratwohl A; Delforge M; Iriondo A; Kuentz M; Harousseau J; Fauser A; Wandt H; Runde V; Niederwieser D; Apperley J;
Genotypically nonidentical related donors for transplantation of patients with myelodysplastic syndromes: comparison with unrelated donor transplantation and autologous stem cell transplantation.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2001;15(12):1878-84.
2001: Maris M; Woolfrey A; McSweeney P A; Sandmaier B M; Nash R A; Georges G; Maloney D G; Molina A; Chauncey T; Yu C; Zaucha J M; Blume K G; Shizuru J; Niederwieser D; Storb R
Nonmyeloablative hematopoietic stem cell transplantation: transplantation for the 21st century.
Frontiers in bioscience : a journal and virtual library 2001;6():G13-6.
2001: Clark R E; Hermans J; Madrigal A; Nachbaur D; Kropshofer G; Gratwohl A; Apperley J; Niederwieser D;
HLA-A3 increases and HLA-DR1 decreases the risk of acute graft-versus-host disease after HLA-matched sibling bone marrow transplantation for chronic myelogenous leukaemia.
British journal of haematology 2001;114(1):36-41.
2001: Deininger M; Pönisch W; Krahl R; Leiblein S; Edel E; Lange T; Fiedler F; Freund M; Franke A; Pasold R; von Grünhagen U; Herold M; Dölken G; Hoffmann F A; Uhle R; Schultze W; Steglich J; Schwarzer A; Richter P; Winkelmann C; Kettner E; Dachselt K; Subert R; Schwalbe E; Doepper J; Helbig W; Niederwieser D;
Chemotherapy for mobilisation of Ph-negative progenitor cells from patients with CML: impact of different mobilisation regimens.
Bone marrow transplantation 2001;27(11):1125-32.
2001: Maris M; Sandmaier B M; Maloney D G; McSweeney P A; Woolfrey A; Chauncey T; Shizuru J; Niederwieser D; Blume K G; Forman S; Storb R
Non-myeloablative hematopoietic stem cell transplantation.
Transfusion clinique et biologique : journal de la Société française de transfusion sanguine 2001;8(3):231-4.
2001: Feinstein L; Sandmaier B; Maloney D; McSweeney P A; Maris M; Flowers C; Radich J; Little M T; Nash R A; Chauncey T; Woolfrey A; Georges G; Kiem H P; Zaucha J M; Blume K G; Shizuru J; Niederwieser D; Storb R
Nonmyeloablative hematopoietic cell transplantation. Replacing high-dose cytotoxic therapy by the graft-versus-tumor effect.
Annals of the New York Academy of Sciences 2001;938():328-37; discussion 337-9.
2001: McSweeney P A; Niederwieser D; Shizuru J A; Sandmaier B M; Molina A J; Maloney D G; Chauncey T R; Gooley T A; Hegenbart U; Nash R A; Radich J; Wagner J L; Minor S; Appelbaum F R; Bensinger W I; Bryant E; Flowers M E; Georges G E; Grumet F C; Kiem H P; Torok-Storb B; Yu C; Blume K G; Storb R F
Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects.
Blood 2001;97(11):3390-400.
2001: Gahrton G; Svensson H; Cavo M; Apperly J; Bacigalupo A; Björkstrand B; Bladé J; Cornelissen J; de Laurenzi A; Facon T; Ljungman P; Michallet M; Niederwieser D; Powles R; Reiffers J; Russell N H; Samson D; Schaefer U W; Schattenberg A; Tura S; Verdonck L F; Vernant J P; Willemze R; Volin L;
Progress in allogenic bone marrow and peripheral blood stem cell transplantation for multiple myeloma: a comparison between transplants performed 1983--93 and 1994--8 at European Group for Blood and Marrow Transplantation centres.
British journal of haematology 2001;113(1):209-16.
2001: Barkholt L; Hentschke P; Zetterquist H; Mattsson J; Uzunel M; Wersäll P; Martola J; Albin N; Aschan J; Wijkström H; Tillegård A; Oman S; Wernerson A; Niederwieser D; Thörne A; Ringdén O
An allogeneic anti-cancer effect after hematopoietic stem cell transplantation.
Transplantation proceedings 2001;33(1-2):1862-4.
2001: Schaumann R; Pönisch W; Helbig J H; Hegenbart U; Ackermann G; Hofmann J; Niederwieser D; Rodloff A C
Pericarditis after allogeneic peripheral blood stem cell transplantation caused by Legionella pneumophila (non-serogroup 1).
Infection 2001;29(1):51-3.
2001: Gratwohl A; Hermans J; Niederwieser D; van Biezen A; van Houwelingen H C; Apperley J;
Female donors influence transplant-related mortality and relapse incidence in male recipients of sibling blood and marrow transplants.
The hematology journal : the official journal of the European Haematology Association / EHA 2001;2(6):363-70.
2000: Storb R; McSweeney P A; Sandmaier B M; Nash R A; Georges G; Maloney D G; Molina A; Chauncey T; Yu C; Zaucha J M; Blume K G; Shizuru J; Niederwieser D
Allogeneic hematopoietic stem cell transplantation: from the nuclear age into the twenty-first century.
Transplantation proceedings 2000;32(7):2548-9.
2000: Nachbaur D; Kropshofer G; Heitger A; Lätzer K; Glassl H; Ludescher C; Nussbaumer W; Niederwieser D
Phenotypic and functional lymphocyte recovery after CD34+-enriched versus non-T cell-depleted autologous peripheral blood stem cell transplantation.
Journal of hematotherapy & stem cell research 2000;9(5):727-36.
2000: Hilbe W; Nussbaumer W; Bonatti H; Thaler J; Niederwieser D; Nachbaur D
Unusual adverse events following peripheral blood stem cell (PBSC) mobilisation using granulocyte colony stimulating factor (G-CSF) in healthy donors.
Bone marrow transplantation 2000;26(7):811-3.
2000: Lass-Flörl C; Rath P; Niederwieser D; Kofler G; Würzner R; Krezy A; Dierich M P
Aspergillus terreus infections in haematological malignancies: molecular epidemiology suggests association with in-hospital plants.
The Journal of hospital infection 2000;46(1):31-5.
2000: de Witte T; Hermans J; Vossen J; Bacigalupo A; Meloni G; Jacobsen N; Ruutu T; Ljungman P; Gratwohl A; Runde V; Niederwieser D; van Biezen A; Devergie A; Cornelissen J; Jouet J P; Arnold R; Apperley J
Haematopoietic stem cell transplantation for patients with myelo-dysplastic syndromes and secondary acute myeloid leukaemias: a report on behalf of the Chronic Leukaemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT).
British journal of haematology 2000;110(3):620-30.
2000: Kopp M; Schweigkofler H; Holzner B; Nachbaur D; Niederwieser D; Fleischhacker W W; Kemmler G; Sperner-Unterweger B
EORTC QLQ-C30 and FACT-BMT for the measurement of quality of life in bone marrow transplant recipients: a comparison.
European journal of haematology 2000;65(2):97-103.
2000: Deininger M; Lehmann T; Krahl R; Hennig E; Müller C; Niederwieser D
No evidence for persistence of BCR-ABL-positive cells in patients in molecular remission after conventional allogenic transplantation for chronic myeloid leukemia.
Blood 2000;96(2):779-80.
2000: Heitger A; Greinix H; Mannhalter C; Mayerl D; Kern H; Eder J; Fink F M; Niederwieser D; Panzer-Grümayer E R
Requirement of residual thymus to restore normal T-cell subsets after human allogeneic bone marrow transplantation.
Transplantation 2000;69(11):2366-73.
2000: Guglielmi C; Arcese W; Hermans J; Bacigalupo A; Bandini G; Bunjes D; Carreras E; Devergie A; Frassoni F; Goldman J; Gratwohl A; Kolb H J; Iori A P; Niederwieser D; Prentice H G; de Witte T; Apperley J
Risk assessment in patients with Ph+ chronic myelogenous leukemia at first relapse after allogeneic stem cell transplant: an EBMT retrospective analysis. The Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation.
Blood 2000;95(11):3328-34.
2000: Posthuma E F; Falkenburg J H; Apperley J F; Gratwohl A; Hertenstein B; Schipper R F; Oudshoorn M; Biezen J H; Hermans J; Willemze R; Roosnek E; Niederwieser D
HLA-DR4 is associated with a diminished risk of the development of chronic myeloid leukemia (CML). Chronic Leukemia Working Party of the European Blood and Marrow Transplant Registry.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2000;14(5):859-62.
2000: Rollinger-Holzinger I; Eibl B; Pauly M; Griesser U; Hentges F; Auer B; Pall G; Schratzberger P; Niederwieser D; Weiss E H; Zwierzina H
LST1: a gene with extensive alternative splicing and immunomodulatory function.
Journal of immunology (Baltimore, Md. : 1950) 2000;164(6):3169-76.
1999: Posthuma E F; Falkenburg J H; Apperley J F; Gratwohl A; Roosnek E; Hertenstein B; Schipper R F; Schreuder G M; D'Amaro J; Oudshoorn M; van Biezen J H; Hermans J; Willemze R; Niederwieser D
HLA-B8 and HLA-A3 coexpressed with HLA-B8 are associated with a reduced risk of the development of chronic myeloid leukemia. The Chronic Leukemia Working Party of the EBMT.
Blood 1999;93(11):3863-5.
1999: Schwinger W; Urban C; Lackner H; Kerbl R; Sovinz P; Gardner H; Peters C; Niederwieser D; Fink F M; Kögler G
Transplantation of related and unrelated umbilical cord blood stem cells in Austria. Austrian Working Party for Stem Cell Transplantation. Austrian Society of Hematology and Oncology.
Wiener klinische Wochenschrift 1999;111(9):348-53.
1999: Heitger A; Kern H; Mayerl D; Maurer K; Nachbaur D; Frühwirth M; Fink F M; Niederwieser D
Effective T cell regeneration following high-dose chemotherapy rescued with CD34+ cell enriched peripheral blood progenitor cells in children.
Bone marrow transplantation 1999;23(4):347-53.
1998: Lass-Flörl C; Kofler G; Kropshofer G; Hermans J; Kreczy A; Dierich M P; Niederwieser D
In-vitro testing of susceptibility to amphotericin B is a reliable predictor of clinical outcome in invasive aspergillosis.
The Journal of antimicrobial chemotherapy 1998;42(4):497-502.
1998: Gratwohl A; Hermans J; Goldman J M; Arcese W; Carreras E; Devergie A; Frassoni F; Gahrton G; Kolb H J; Niederwieser D; Ruutu T; Vernant J P; de Witte T; Apperley J
Risk assessment for patients with chronic myeloid leukaemia before allogeneic blood or marrow transplantation. Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation.
Lancet 1998;352(9134):1087-92.
1998: Hilbe W; Apfelbeck U; Fridrik M; Bernhart M; Niessner H; Abbrederis K; Michlmayr G; Pont J; Linkesch W; Hausmaninger H; Arneitz K; Baldinger C; Duba C; Eisterer W; Greil R; Konwalinka G; Niederwieser D; Gastl G; Thaler J
Interferon-alpha for the treatment of elderly patients with chronic myeloid leukaemia.
Leukemia research 1998;22(10):881-6.
1998: Graziadei I; Weiss G; Egger C; Niederwieser D; Patsch J R; Vogel W
Modulation of iron metabolism in monocytic THP-1 cells and cultured human monocytes by the acute-phase protein alpha1-antitrypsin.
Experimental hematology 1998;26(11):1053-60.
1998: Ruutu T; Hermans J; van Biezen A; Niederwieser D; Gratwohl A; Apperley J F
How should corticosteroids be used in the treatment of acute GVHD? EBMT Chronic Leukemia Working Party. European Group for Blood and Marrow Transplantation.
Bone marrow transplantation 1998;22(6):614-5.
1998: Kopp M; Schweigkofler H; Holzner B; Nachbaur D; Niederwieser D; Fleischhacker W W; Sperner-Unterweger B
Time after bone marrow transplantation as an important variable for quality of life: results of a cross-sectional investigation using two different instruments for quality-of-life assessment.
Annals of hematology 1998;77(1-2):27-32.
1998: Nachbaur D; Herold M; Gächter A; Niederwieser D
Modulation of alloimmune response in vitro by an IgM-enriched immunoglobulin preparation (Pentaglobin).
Immunology 1998;94(2):279-83.
1998: Runde V; de Witte T; Arnold R; Gratwohl A; Hermans J; van Biezen A; Niederwieser D; Labopin M; Walter-Noel M P; Bacigalupo A; Jacobsen N; Ljungman P; Carreras E; Kolb H J; Aul C; Apperley J
Bone marrow transplantation from HLA-identical siblings as first-line treatment in patients with myelodysplastic syndromes: early transplantation is associated with improved outcome. Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation.
Bone marrow transplantation 1998;21(3):255-61.
1997: Nachbaur D; Fink F M; Nussbaumer W; Gächter A; Kropshofer G; Ludescher C; Niederwieser D
CD34+-selected autologous peripheral blood stem cell transplantation (PBSCT) in patients with poor-risk hematological malignancies and solid tumors. A single-centre experience.
Bone marrow transplantation 1997;20(10):827-34.
1997: Eibl B; Ebner S; Duba C; Böck G; Romani N; Erdel M; Gächter A; Niederwieser D; Schuler G
Dendritic cells generated from blood precursors of chronic myelogenous leukemia patients carry the Philadelphia translocation and can induce a CML-specific primary cytotoxic T-cell response.
Genes, chromosomes & cancer 1997;20(3):215-23.
1997: Ladenstein R; Peters C; Minkov M; Emminger-Schmidmeier W; Mann G; Höcker P; Hawliczek R; Rosenmayr A; Fink F M; Niederwieser D; Gadner H
A single centre experience with allogeneic stem cell transplantation for severe aplastic anaemia in childhood.
Klinische Pädiatrie 1997;209(4):201-8.
1997: Heitger A; Neu N; Kern H; Panzer-Grümayer E R; Greinix H; Nachbaur D; Niederwieser D; Fink F M
Essential role of the thymus to reconstitute naive (CD45RA+) T-helper cells after human allogeneic bone marrow transplantation.
Blood 1997;90(2):850-7.
1997: Geissler K; Koller E; Hubmann E; Niederwieser D; Hinterberger W; Geissler D; Kyrle P; Knöbl P; Pabinger I; Thalhammer R; Schwarzinger I; Mannhalter C; Jaeger U; Heinz R; Linkesch W; Lechner K
Granulocyte colony-stimulating factor as an adjunct to induction chemotherapy for adult acute lymphoblastic leukemia--a randomized phase-III study.
Blood 1997;90(2):590-6.
1997: Nachbaur D; Kropshofer G; Feichtinger H; Allerberger F; Niederwieser D
Cryptosporidiosis after CD34-selected autologous peripheral blood stem cell transplantation (PBSCT). Treatment with paromomycin, azithromycin and recombinant human interleukin-2.
Bone marrow transplantation 1997;19(12):1261-3.
1997: Speiser D E; Hermans J; van Biezen A; Starobinski M; Jeannet M; Jacobsen N; Niederwieser D; Gratwohl A; Apperley J F
Haploidentical family member transplants for patients with chronic myeloid leukaemia: a report of the Chronic Leukaemia Working Party of off European Group for Blood and Marrow Transplantation (EBMT).
Bone marrow transplantation 1997;19(12):1197-203.
1997: Nachbaur D; Duba H C; Feichtinger H; Kropshofer G; Nussbaumer W; Schwaighofer H; Niederwieser D
Polychemotherapy combined with G-CSF-mobilized donor buffy coat transfusion for granulocytic sarcoma after allogeneic BMT for AML.
Bone marrow transplantation 1997;19(9):947-9.
1997: Keil F; Haas O A; Fritsch G; Kalhs P; Lechner K; Mannhalter C; Reiter E; Niederwieser D; Hoecker P; Greinix H T
Donor leukocyte infusion for leukemic relapse after allogeneic marrow transplantation: lack of residual donor hematopoiesis predicts aplasia.
Blood 1997;89(9):3113-7.
1997: Ruutu T; Niederwieser D; Gratwohl A; Apperley J F
A survey of the prophylaxis and treatment of acute GVHD in Europe: a report of the European Group for Blood and Marrow, Transplantation (EBMT). Chronic Leukaemia Working Party of the EBMT.
Bone marrow transplantation 1997;19(8):759-64.
1997: Nachbaur D; Herold M; Eibl B; Glassl H; Schwaighofer H; Huber C; Gächter A; Pichl M; Niederwieser D
A comparative study of the in vitro immunomodulatory activity of human intact immunoglobulin (7S IVIG), F(ab')2 fragments (5S IVIG) and Fc fragments. Evidence for post-transcriptional IL-2 modulation.
Immunology 1997;90(2):212-8.
1997: Schett G; Metzler B; Mayr M; Amberger A; Niederwieser D; Gupta R S; Mizzen L; Xu Q; Wick G
Macrophage-lysis mediated by autoantibodies to heat shock protein 65/60.
Atherosclerosis 1997;128(1):27-38.
1997: Thaler J; Hilbe W; Apfelbeck U; Linkesch W; Sill H; Seewann H; Pont J; Bernhart M; Stöger M; Niessner H; Abbrederis K; Geissler D; Hausmaninger H; Lin W; Ludwig H; Lang A; Duba C; Fluckinger T; Greil R; Grünewald K; Konwalinka G; Niederwieser D; Fridrik M
Interferon-alpha-2C and LD ara-C for the treatment of patients with CML: results of the Austrian multi-center phase II study.
Leukemia research 1997;21(1):75-80.
1997: Schwaighofer H; Oberhuber G; Hebart H; Einsele H; Herold M; Nachbaur D; Eibl B; Tilg H; Kropshofer G; Ferrara J L; Niederwieser D
Endogenous interleukin 1 receptor antagonist during human bone marrow transplantation: increased levels during graft-versus-host disease, during infectious complications, and after immunoglobulin therapy.
Transplantation 1997;63(1):52-6.
1996: Gratwohl A; Hermans J; van Biezen A; Arcese W; Debusscher L; Ernst P; Ferrant A; Frassoni F; Gahrton G; Iriondo A; Kolb H J; Link H; Niederwieser D; Ruutu T; Siegert W; Zwaan F E
Splenic irradiation before bone marrow transplantation for chronic myeloid leukaemia. Chronic Leukaemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT)
British journal of haematology 1996;95(3):494-500.
1996: Schwaighofer H; Kernan N A; O'Reilly R J; Brankova J; Nachbaur D; Herold M; Eibl B; Niederwieser D
Serum levels of cytokines and secondary messages after T-cell-depleted and non-T-cell-depleted bone marrow transplantation: influence of conditioning and hematopoietic reconstitution.
Transplantation 1996;62(7):947-53.
1996: Huter O; Brezinka C; Nachbaur D; Schwaighofer H; Lang A; Niederwieser D
Successful treatment of primary extramedullary leukemia (EML) of the uterus with radical surgery, chemotherapy, autologous bone marrow transplantation (BMT) and prophylactic local irradiation.
Bone marrow transplantation 1996;18(3):663-4.
1996: Romani N; Reider D; Heuer M; Ebner S; Kämpgen E; Eibl B; Niederwieser D; Schuler G
Generation of mature dendritic cells from human blood. An improved method with special regard to clinical applicability.
Journal of immunological methods 1996;196(2):137-51.
1996: Eibl B; Schwaighofer H; Nachbaur D; Marth C; Gächter A; Knapp R; Böck G; Gassner C; Schiller L; Petersen F; Niederwieser D
Evidence for a graft-versus-tumor effect in a patient treated with marrow ablative chemotherapy and allogeneic bone marrow transplantation for breast cancer.
Blood 1996;88(4):1501-8.
1996: Nussbaumer W; Schönitzer D; Trieb T; Fink F M; Maurer-Dengg K; Höcker P; Wagner A; Schwaighofer H; Nachbaur D; Niederwieser D
Peripheral blood stem cell (PBSC) collection in extremely low-weight infants.
Bone marrow transplantation 1996;18(1):15-7.
1996: Thaler J; Gastl G; Fluckinger T; Niederwieser D; Huber H; Seewann H; Sill H; Lang A; Falk M; Duba C; Utermann G; Kühr T; Aulitzky W; Huber C
Interferon alpha-2c therapy of patients with chronic myelogenous leukemia: long-term results of a multicenter phase-II study. Austrian Biological Response Modifier (BRM) Study Group.
Annals of hematology 1996;72(6):349-55.
1996: Geissler K; Peschel C; Niederwieser D; Strobl H; Goldschmitt J; Ohler L; Bettelheim P; Kahls P; Huber C; Lechner K; Höcker P; Kolbe K
Potentiation of granulocyte colony-stimulating factor-induced mobilization of circulating progenitor cells by seven-day pretreatment with interleukin-3.
Blood 1996;87(7):2732-9.
1996: Knapp R; Bangerl I; zur Nedden D; Nachbaur D; Niederwieser D
Aspergillosis in acute myelogenous leukemia.
International archives of allergy and immunology 1996;109(2):115.
1996: Nachbaur D; Niederwieser D; Aichinger G; Aulitzky W; Tilg H; Eibl B; König P; Gattringer C; Majdic O; Stockinger H; Margreiter R; Oberhuber G; Födinger A M; Schwaighofer H; Huber C
CD4 monoclonal antibody VIT4 in human alloimmune response in vitro and in vivo.
Immunobiology 1996;195(1):33-46.
1996: Ebenbichler C F; Würzner R; Sandhofer A D; Niederwieser D; Dierich M P; Patsch J R
Anti-thymocyte globulin treatment of a patient for paroxysmal nocturnal haemoglobinuria-aplastic anaemia syndrome: complement activation and transient decrease of the PNH clone.
Immunobiology 1996;196(5):513-21.
1995: Weiss G; Schwaighofer H; Herold M; Nachbaur D; Wachter H; Niederwieser D; Werner E R
Nitric oxide formation as predictive parameter for acute graft-versus-host disease after human allogeneic bone marrow transplantation.
Transplantation 1995;60(11):1239-44.
1995: Geissler K; Peschel C; Niederwieser D; Goldschmitt J; Hladik F; Fritz A; Ohler L; Bettelheim P; Huber C; Lechner K
Effect of interleukin-3 pretreatment on granulocyte/macrophage colony-stimulating factor induced mobilization of circulating haemopoietic progenitor cells.
British journal of haematology 1995;91(2):299-305.
1995: Kolb H J; Schattenberg A; Goldman J M; Hertenstein B; Jacobsen N; Arcese W; Ljungman P; Ferrant A; Verdonck L; Niederwieser D; van Rhee F; Mittermueller J; de Witte T; Holler E; Ansari H;
Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients.
Blood 1995;86(5):2041-50.
1995: Nussbaumer W; Schwaighofer H; Gratwohl A; Kilga S; Schönitzer D; Nachbaur D; Niederwieser D
Transfusion of donor-type red cells as a single preparative treatment for bone marrow transplants with major ABO incompatibility.
Transfusion 1995;35(7):592-5.
1995: Niederwieser D; Eibl B; Nachbaur D
Graft-versus-host disease after autologous bone marrow transplantation: a realistic expectation?
Wiener medizinische Wochenschrift (1946) 1995;145(2-3):25-7.
1994: Hilbe W; Thaler J; Eisterer W; Ludescher C; Niederwieser D
Treatment of relapsed and refractory acute myelogenous leukaemia with aclacinomycin A (ACA) and etoposide (VP-16).
Leukemia research 1994;18(9):655-8.
1994: Schwarzinger I; Raff R F; Flowers M; Niederwieser D; Graham T; Shulman H; Appelbaum F R; Schuening F; Storb R
Recipient-specific donor cytotoxic T lymphocytes enhance engraftment of unrelated, DLA non-identical canine marrow.
Bone marrow transplantation 1994;13(3):303-9.
1994: Nachbaur D; Schwaighofer H; Petersen F; Thaler J; Nussbaumer W; Fend F; Niederwieser D
Successful second transplant from an HLA-identical unrelated donor after graft rejection in a patient with chronic myelogenous leukemia.
Transplantation 1994;57(3):478-80.
1994: Nachbaur D; Schwaighofer H; Thaler J; Weyrer W; Fink M; Nussbaumer W; Fritsch E; Niederwieser D
[Innsbruck results of bone marrow transplantation in treatment of hematologic neoplasms and solid tumors]
Wiener klinische Wochenschrift 1994;106(7):201-7.
1993: Gratwohl A; Hermans J; Niederwieser D; Frassoni F; Arcese W; Gahrton G; Bandini G; Carreras E; Vernant J P; Bosi A
Bone marrow transplantation for chronic myeloid leukemia: long-term results. Chronic Leukemia Working Party of the European Group for Bone Marrow Transplantation.
Bone marrow transplantation 1993;12(5):509-16.
1993: Allerberger F; Fassl A; Niederwieser D; Zangerle R; Lingnau W; Dierich M P
In vitro susceptibility of Candida albicans, Austria 1992.
Mycoses 1993;36(11-12):411-6.
1993: Tilg H; Eibl B; Pichl M; Gächter A; Herold M; Brankova J; Huber C; Niederwieser D
Immune response modulation by pentoxifylline in vitro.
Transplantation 1993;56(1):196-201.
1993: Niederwieser D; Arcese W; Bandini G; Schwaighofer H; Thaler J; Bosi A; Di Bartolomeo P; Alessandrino E P; Urban C; Gratwohl A
Prophylactic use of interferon alfa after bone marrow transplantation for patients with chronic myelogenous leukemia at high risk of relapse: a pilot study. The Chronic Leukemia Working Party of the EBMT.
Seminars in hematology 1993;30(3 Suppl 3):40-3.
1993: Thaler J; Gastl G; Fluckinger T; Niederwieser D; Huber H; Seewann H; Silly H; Lang A; Abbrederis C; Gadner H
Treatment of chronic myelogenous leukemia with interferon alfa-2c: response rate and toxicity in a phase II multicenter study. The Austrian Biological Response Modifier (BRM) Study Group.
Seminars in hematology 1993;30(3 Suppl 3):17-9.
1993: Niederwieser D; Grassegger A; Auböck J; Herold M; Nachbaur D; Rosenmayr A; Gächter A; Nussbaumer W; Gaggl S; Ritter M
Correlation of minor histocompatibility antigen-specific cytotoxic T lymphocytes with graft-versus-host disease status and analyses of tissue distribution of their target antigens.
Blood 1993;81(8):2200-8.
1993: Nachbaur D; Gratwohl A; Herold M; Tichelli A; Slanicka M; Nissen C; Niederwieser D; Speck B
Cytokine serum levels during treatment with high-dose recombinant human IL-3 in a patient with severe aplastic anemia.
Annals of hematology 1993;66(2):71-5.
1992: Niederwieser D; Granena A; Hermans J; Kolb H J; Zwaan F; Gratwohl A
Slow response to induction chemotherapy is an indicator of poor survival after bone marrow transplantation for acute lymphoblastic leukemia. The Leukemia Working Party of the European Group of Bone Marrow Transplantation (EBMT).
Bone marrow transplantation 1992;9(6):439-43.
1992: Allerberger F; Prior C; Niederwieser D; Dierich M P
[Calcofluor-white staining in the identification of Pneumocystis carinii]
Pneumologie (Stuttgart, Germany) 1992;46(4):158-9.
1992: Irschick E U; Hladik F; Niederwieser D; Nussbaumer W; Holler E; Kaminski E; Huber C
Studies on the mechanism of tolerance or graft-versus-host disease in allogeneic bone marrow recipients at the level of cytotoxic T-cell precursor frequencies.
Blood 1992;79(6):1622-8.
1991: Aulitzky W E; Schulz T F; Tilg H; Niederwieser D; Larcher K; Ostberg L; Scriba M; Martindale J; Stern A C; Grass P
Human monoclonal antibodies neutralizing cytomegalovirus (CMV) for prophylaxis of CMV disease: report of a phase I trial in bone marrow transplant recipients.
The Journal of infectious diseases 1991;163(6):1344-7.
1991: Thaler J; Kühr T; Gastl G; Huber H; Duba C; Kemmler G; Gattringer C; Fluckinger T; Niederwieser D; Seewann H
[Recombinant interferon alpha-2c in Ph-positive chronic myeloid leukemia. Results of a multicenter phase II study]
Deutsche medizinische Wochenschrift (1946) 1991;116(19):721-8.
1991: Niederwieser D; Granena A; Hermans J; Kolb H J; Zwaan F; Gratwohl A
Time intervals influence outcome of bone marrow transplantation (BMT) in patients with acute lymphoblastic leukemia. The Leukemia Working Party of EBMT.
Bone marrow transplantation 1991;7 Suppl 2():35.
1990: Ljungman P; Niederwieser D; Pepe M S; Longton G; Storb R; Meyers J D
Cytomegalovirus infection after marrow transplantation for aplastic anemia.
Bone marrow transplantation 1990;6(5):295-300.
1990: Niederwieser D; Herold M; Woloszczuk W; Aulitzky W; Meister B; Tilg H; Gastl G; Bowden R; Huber C
Endogenous IFN-gamma during human bone marrow transplantation. Analysis of serum levels of interferon and interferon-dependent secondary messages.
Transplantation 1990;50(4):620-5.
1990: Irschick E; Hladik F; Berger M; Niederwieser D; Herzog W; Zanker B; Kabelitz D; Margreiter K; Auböck J; Miller K
Clonal reduction of CTL-P and acquired allograft tolerance in various human transplantation models.
Transplantation proceedings 1990;22(4):1869-70.
1990: Niederwieser D W; Appelbaum F R; Gastl G; Gersdorf E; Meister B; Geissler D; Tratkiewicz J A; Thaler J; Huber C
Inadvertent transmission of a donor's acute myeloid leukemia in bone marrow transplantation for chronic myelocytic leukemia.
The New England journal of medicine 1990;322(25):1794-6.
1990: Flowers M E; Stockschlaeder M A; Schuening F G; Niederwieser D; Hackman R; Miller A D; Storb R
Long-term transplantation of canine keratinocytes made resistant to G418 through retrovirus-mediated gene transfer.
Proceedings of the National Academy of Sciences of the United States of America 1990;87(6):2349-53.
1990: Huber C; Niederwieser D
Role of cytokines and major histocompatibility complex antigens in graft-versus-host disease: in vitro studies using T-cell lines and keratinocytes or hemopoietic targets.
Haematology and blood transfusion 1990;33():652-4.
1989: Niederwieser D; Pepe M; Storb R; Witherspoon R; Longton G; Sullivan K
Factors predicting chronic graft-versus-host disease and survival after marrow transplantation for aplastic anemia.
Bone marrow transplantation 1989;4(2):151-6.
1988: Geissler D; Niederwieser D; Aulitzky W E; Tilg H; Grünewald K; Huber C; Konwalinka G
Serum colony stimulating factors in patients undergoing bone marrow transplantation: enhancing effect of recombinant human GM-CSF.
Behring Institute Mitteilungen 1988;(83):289-300.
1988: Aulitzky W E; Tilg H; Niederwieser D; Hackl M; Meister B; Huber C
Ganciclovir and hyperimmunoglobulin for treating cytomegalovirus infection in bone marrow transplant recipients.
The Journal of infectious diseases 1988;158(2):488-9.
1988: Aulitzky W E; Tilg H; Niederwieser D; Riccabona G; Obendorf L; Margreiter R; Pfaller W; Huber C
Comparison of serum neopterin levels and urinary neopterin excretion in renal allograft recipients.
Clinical nephrology 1988;29(5):248-52.
1988: Niederwieser D; Pepe M; Storb R; Loughran T P; Longton G
Improvement in rejection, engraftment rate and survival without increase in graft-versus-host disease by high marrow cell dose in patients transplanted for aplastic anaemia.
British journal of haematology 1988;69(1):23-8.
1988: Niederwieser D; Auböck J; Troppmair J; Herold M; Schuler G; Boeck G; Lotz J; Fritsch P; Huber C
IFN-mediated induction of MHC antigen expression on human keratinocytes and its influence on in vitro alloimmune responses.
Journal of immunology (Baltimore, Md. : 1950) 1988;140(8):2556-64.
1988: Miller K; Huber C; Niederwieser D; Göttinger W
Successful engraftment of high-risk corneal allografts with short-term immunosuppression with cyclosporine.
Transplantation 1988;45(3):651-3.
1988: Troppmair J; Auböck J; Niederwieser D; Schönitzer D; Huber C
Interferons (IFNs) and tumor necrosis factors (TNFs) in T cell-mediated immune responses against alloantigens. I. Influence on the activation of resting and antigen-primed T cells.
Immunobiology 1988;176(3):236-54.
1987: Schönitzer D; Tilg H; Niederwieser D; Aulitzky W; Margreiter R; Huber C H
ABO-incompatible renal transplantation: report of two transplants from AB donors to A recipients.
Transplantation proceedings 1987;19(6):4547-8.
1987: Niederwieser D; Gastl G; Rumpold H; Marth C; Kraft D; Huber C
Rapid reappearance of large granular lymphocytes (LGL) with concomitant reconstitution of natural killer (NK) activity after human bone marrow transplantation (BMT).
British journal of haematology 1987;65(3):301-5.
1987: Steiner E; Klima G; Niederwieser D; Königsrainer A; Herold M; Margreiter R
Monitoring of the pancreatic allograft by analysis of exocrine secretion.
Transplantation proceedings 1987;19(1 Pt 3):2336-8.
1987: Margreiter R; Niederwieser D; Frommhold H; Schönitzer D; Gratwohl A; Huber C
Tumor recurrence after liver transplantation followed by high-dose cyclophosphamide, total body irradiation, and autologous bone marrow transplantation for treatment of metastatic liver disease.
Transplantation proceedings 1987;19(1 Pt 3):2403-4.
1987: Niederwieser D; Aulitzky W; Frommhold H; Schönitzer D; Url M; Allerberger F; Wiegele J; Gratwohl A; Braunsteiner H; Huber C
[Experience using bone marrow transplantation in the treatment of hematologic neoplasms and solid tumors]
Wiener klinische Wochenschrift 1987;99(2):49-53.
1986: Prior C; Bollbach R; Fuchs D; Hausen A; Judmaier G; Niederwieser D; Reibnegger G; Rotthauwe H W; Werner E R; Wachter H
Urinary neopterin, a marker of clinical activity in patients with Crohn's disease.
Clinica chimica acta; international journal of clinical chemistry 1986;155(1):11-21.
1986: Huber C; Irschik E; Leiter E; Binz H; Niederwieser D; Spielberger M; Kathrein H; Schönitzer D; Margreiter R
Use of donor-specific T-cell lines for monitoring of human allograft recipients. I. Demonstration of IgG binding to autologous TCL.
Experimental cell biology 1986;54(1):16-24.
1985: Niederwieser D; Fuchs D; Hausen A; Judmaier G; Reibnegger G; Wachter H; Huber C
Neopterin as a new biochemical marker in the clinical assessment of ulcerative colitis.
Immunobiology 1985;170(4):320-6.
1985: Miller K; Kieselbach G F; Niederwieser D; Huber C; Margreiter R; Göttinger W
[Immunosuppression with cyclosporin A in high-risk keratoplasties]
Klinische Monatsblätter für Augenheilkunde 1985;187(5):394-7.
1985: Gastl G; Denz H; Abbrederis C; Huber H; Troppmair J; Wiegele J; Niederwieser D; Flener R; Huber C
Treatment with low dose human recombinant interferon-alpha-2-ARG induces complete remission in patients with hairy cell leukemia.
Onkologie 1985;8(3):143-4.
1985: Irschick E U; Niederwieser D; Lochs A; Spielberger M; Gattringer C; Margreiter R; Huber C
Follow-up studies on proliferative T cell responses in cadaveric kidney graft recipients under combined immunosuppressive treatment with cyclosporine and prednisone.
Immunobiology 1985;169(2):128-38.
1985: Werner E R; Lutz H; Fuchs D; Hausen A; Huber C; Niederwieser D; Pfleiderer W; Reibnegger G; Troppmair J; Wachter H
Identification of 3-hydroxyanthranilic acid in mixed lymphocyte cultures.
Biological chemistry Hoppe-Seyler 1985;366(1):99-102.
1985: Auböck J; Niederwieser D; Romani N; Fritsch P; Huber C
Human interferon-gamma induces expression of HLA-DR on keratinocytes and melanocytes.
Archives of dermatological research 1985;277(4):270-5.
1985: Leiter E; Pfister R; Tilg H; Niederwieser D; Kathrein H; Spielberger M; Margreiter R; Huber C
Evaluation of spontaneous lymphocyte proliferation by single cell autoradiography in human allograft recipients.
Immunology letters 1985;11(5-6):311-6.
1985: Niederwieser D; Albert E; Fuchs D; Hausen A; Margreiter R; Reibnegger G; Schönitzer D; Troppmair J; Wachter H; Huber C
Neopterin release in human mixed lymphocyte culture: requirement of HLA-DR disparity.
Immunology letters 1985;11(2):95-9.
1984: Niederwieser D; Huber C; Gratwohl A; Bannert P; Fuchs D; Hausen A; Reibnegger G; Speck B; Wachter H
Neopterin as a new biochemical marker in the clinical monitoring of bone marrow transplant recipients.
Transplantation 1984;38(5):497-500.
1984: Irschik E; Tilg H; Niederwieser D; Gastl G; Huber C; Margreiter R
Cyclosporin blood levels do correlate with clinical complications.
Lancet 1984;2(8404):692-3.
1984: Huber C; Batchelor J R; Fuchs D; Hausen A; Lang A; Niederwieser D; Reibnegger G; Swetly P; Troppmair J; Wachter H
Immune response-associated production of neopterin. Release from macrophages primarily under control of interferon-gamma.
The Journal of experimental medicine 1984;160(1):310-6.
1984: Gastl G; Niederwieser D; Marth C; Huber H; Egg D; Schuler G; Margreiter R; Braunsteiner H; Huber C
Human large granular lymphocytes and their relationship to natural killer cell activity in various disease states.
Blood 1984;64(1):288-95.
1984: Margreiter R; Kramar R; Huber C; Steiner E; Niederwieser D; Judmaier G; Vogel W
Combined liver and kidney transplantation.
Lancet 1984;1(8385):1077-8.
1984: Huber C; Niederwieser D; Schönitzer D; Gratwohl A; Buckner D; Margreiter R
Liver transplantation followed by high-dose cyclophosphamide, total-body irradiation, and autologous bone marrow transplantation for treatment of metastatic breast cancer. A case report.
Transplantation 1984;37(3):311-2.
1984: Huber C; Fuchs D; Niederwieser D; Hausen A; Reibnegger G; Nilsson K; Wachter H
[Neopterin, a new biochemical marker for clinical assessment of cell-mediated immune response]
Klinische Wochenschrift 1984;62(3):103-13.
1983: Niederwieser D; Gratwohl A; Oberholzer M; Osterwalder B; Nissen C; Speck B
Bone marrow cell dose and kinetics of recovery following allogeneic marrow transplantation in man.
Blut 1983;47(6):355-60.
1983: Niederwieser D; Huber C; Wachter H
[Neopterin, a new biochemical marker for the detection of activated T lymphocytes]
Wiener klinische Wochenschrift 1983;95(5):161-4.
1983: Gastl G; Niederwieser D; Huber C
[Large, granular lymphocytes, a new population of mononuclear blood cells]
Wiener klinische Wochenschrift 1983;95(5):154-8.
1982: Huber C; Lutz D; Niederwieser D; Weiser G; Dietze O; Theml H; Braunsteiner H
Prognostic significance of lymphocyte density distribution profiles in adult non-Hodgkin lymphomas.
Blood 1982;60(6):1397-401.
1982: Huber C; Niederwieser D; Gastl G; Zier K; Braunsteiner H
[Density distribution of human lymphocytes. I. Results of research on normal lymphoid tissue]
Blut 1982;45(6):375-83.
1982: Niederwieser D; Huber C; Lutz D; Weiser G; Theml H; Braunsteiner H
[Density distribution of human lymphocytes. II. Distribution patterns of malignant lymphocytes and their prognostic significance in patients with non-Hodgkin's lymphoma]
Blut 1982;45(6):385-94.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Dietger Niederwieser

Research Profile (preview)

Procedures

Disorders

Concepts & Ideas

Phenomena

Living Beings

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Dietger Niederwieser (preview)

All Publications